WilliamTeo的个人主页 - 老虎社区

WilliamTeo

WilliamTeo

暂无个人介绍

IP属地：未知

130关注

6粉丝

0主题

0勋章

2021-03-22

$GameStop(GME)$diamond hand here

2021-07-17

$Gaotu Techedu Inc.(GOTU)$omg. Trash stock

2021-03-10

Go higher higher

The Equity-Gold Price Conundrum, Part 1: The Great Batsby<blockquote>股票-黄金价格难题，第1部分：伟大的蝙蝠侠</blockquote>

2021-05-09

Go for it

抱歉，原内容已删除

2021-04-26

$Tiger Brokers(TIGR)$cry tiger

2021-08-12

All the way

BioNTech, Moderna Gain on Report of FDA’s Likely Nod for Booster<blockquote>BioNTech和Moderna因FDA可能批准增强剂的报道而上涨</blockquote>

2021-05-25

Go up and down

Moderna shares once gained more than 4%<blockquote>Moderna股价一度涨超4%</blockquote>

2021-04-21

$Snowflake(SNOW)$winter snow

2021-04-02

$CN Energy Group Inc.(CNEY)$when going up

2021-07-03

Go there

抱歉，原内容已删除

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3575416215572570","uuid":"3575416215572570","gmtCreate":1612342668405,"gmtModify":1613096802979,"name":"WilliamTeo","pinyin":"williamteo","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":6,"headSize":130,"tweetSize":174,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-2","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"资深虎友","description":"加入老虎社区1000天","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.11.01","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"228c86a078844d74991fff2b7ab2428d-3","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资合伙人虎","description":"证券账户累计交易金额达到100万美元","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.11.03","exceedPercentage":"93.69%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.01.30","exceedPercentage":"80.60%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":12,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":894761578,"gmtCreate":1628858017494,"gmtModify":1631892264502,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575416215572570","authorIdStr":"3575416215572570"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/894761578","repostId":"2159294386","repostType":4,"isVote":1,"tweetType":1,"viewCount":3209,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":894990649,"gmtCreate":1628780633881,"gmtModify":1631892264507,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575416215572570","authorIdStr":"3575416215572570"},"themes":[],"htmlText":"All the way","listText":"All the way","text":"All the way","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/894990649","repostId":"2158325931","repostType":4,"repost":{"id":"2158325931","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1628776169,"share":"https://www.laohu8.com/m/news/2158325931?lang=zh_CN&edition=full","pubTime":"2021-08-12 21:49","market":"us","language":"en","title":"BioNTech, Moderna Gain on Report of FDA’s Likely Nod for Booster<blockquote>BioNTech和Moderna因FDA可能批准增强剂的报道而上涨</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=2158325931","media":"Tiger Newspress","summary":"BioNTech and Moderna stock rose in early trading on Thursday, on track to recover some of the previo","content":"<p>BioNTech&nbsp;and Moderna&nbsp;stock rose in&nbsp;early&nbsp;trading&nbsp;on Thursday, on track to recover some of the previous session’s losses, following a report in the Wall Street Journal that the FDA could authorize Covid-19 booster shots for immunocompromised people.</p><p><blockquote>BioNTech和Moderna股价周四早盘上涨，有望收复前一交易日的部分跌幅，此前《华尔街日报》报道称FDA可能授权为免疫功能低下的人注射Covid-19加强针。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/2860e1c0dcbf5f35624516c9d0ff29db\" tg-width=\"895\" tg-height=\"647\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> BioNTech and Moderna were up 3.96% and 2% after plunging 14% and 15.6% in the previous session, respectively. Pfizer (NYSE:PFE), which shed 4% on Wednesday, was up 1%.</p><p><blockquote>BioNTech和Moderna在前一交易日分别暴跌14%和15.6%后上涨3.96%和2%。辉瑞(NYSE：PFE)周三下跌4%，现上涨1%。</blockquote></p><p> The WSJ reported that the Food and Drug Administration is nearing a decision to authorize booster shots for people with weak immunity amid a surge in new COVID cases because of the rapid spread of the delta variant.</p><p><blockquote>《华尔街日报》报道称，由于德尔塔变异毒株的快速传播，新冠病例激增，美国食品和药物管理局即将决定授权为免疫力较弱的人进行加强注射。</blockquote></p><p> There is growing evidence that two shots of the vaccines are inadequate for people with low immunity. Vaccine makers plan to approach the FDA this month or next for approval to their booster shots.</p><p><blockquote>越来越多的证据表明，对于免疫力低下的人来说，两针疫苗是不够的。疫苗制造商计划在本月或下个月向FDA申请加强注射的批准。</blockquote></p><p> BioNTech, Moderna and Pfizer all closed lower Wednesday following news that Europe’s drug regulator is studying three new conditions reported by a small number of people after getting Covid-19 shots to assess if they may be possible side-effects.</p><p><blockquote>BioNTech、Moderna和辉瑞周三均收低，此前有消息称，欧洲药品监管机构正在研究少数人在接种Covid-19疫苗后报告的三种新病症，以评估它们是否可能是副作用。</blockquote></p><p> The conditions were reported in patients who took the mRNA vaccines made by either Moderna or BioNTech-Pfizer.</p><p><blockquote>据报道，服用Moderna或BioNTech-Pfizer生产的mRNA疫苗的患者出现了这种情况。</blockquote></p><p> Pfizer and BioNTech are collaborating on the research and marketing of their COVID-19 vaccine. Expenses and profit from the vaccine are split equally between Pfizer and BioNTech.</p><p><blockquote>辉瑞和BioNTech正在合作研究和营销他们的新冠肺炎疫苗。疫苗的费用和利润由辉瑞和BioNTech平分。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BioNTech, Moderna Gain on Report of FDA’s Likely Nod for Booster<blockquote>BioNTech和Moderna因FDA可能批准增强剂的报道而上涨</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBioNTech, Moderna Gain on Report of FDA’s Likely Nod for Booster<blockquote>BioNTech和Moderna因FDA可能批准增强剂的报道而上涨</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-08-12 21:49</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>BioNTech&nbsp;and Moderna&nbsp;stock rose in&nbsp;early&nbsp;trading&nbsp;on Thursday, on track to recover some of the previous session’s losses, following a report in the Wall Street Journal that the FDA could authorize Covid-19 booster shots for immunocompromised people.</p><p><blockquote>BioNTech和Moderna股价周四早盘上涨，有望收复前一交易日的部分跌幅，此前《华尔街日报》报道称FDA可能授权为免疫功能低下的人注射Covid-19加强针。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/2860e1c0dcbf5f35624516c9d0ff29db\" tg-width=\"895\" tg-height=\"647\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> BioNTech and Moderna were up 3.96% and 2% after plunging 14% and 15.6% in the previous session, respectively. Pfizer (NYSE:PFE), which shed 4% on Wednesday, was up 1%.</p><p><blockquote>BioNTech和Moderna在前一交易日分别暴跌14%和15.6%后上涨3.96%和2%。辉瑞(NYSE：PFE)周三下跌4%，现上涨1%。</blockquote></p><p> The WSJ reported that the Food and Drug Administration is nearing a decision to authorize booster shots for people with weak immunity amid a surge in new COVID cases because of the rapid spread of the delta variant.</p><p><blockquote>《华尔街日报》报道称，由于德尔塔变异毒株的快速传播，新冠病例激增，美国食品和药物管理局即将决定授权为免疫力较弱的人进行加强注射。</blockquote></p><p> There is growing evidence that two shots of the vaccines are inadequate for people with low immunity. Vaccine makers plan to approach the FDA this month or next for approval to their booster shots.</p><p><blockquote>越来越多的证据表明，对于免疫力低下的人来说，两针疫苗是不够的。疫苗制造商计划在本月或下个月向FDA申请加强注射的批准。</blockquote></p><p> BioNTech, Moderna and Pfizer all closed lower Wednesday following news that Europe’s drug regulator is studying three new conditions reported by a small number of people after getting Covid-19 shots to assess if they may be possible side-effects.</p><p><blockquote>BioNTech、Moderna和辉瑞周三均收低，此前有消息称，欧洲药品监管机构正在研究少数人在接种Covid-19疫苗后报告的三种新病症，以评估它们是否可能是副作用。</blockquote></p><p> The conditions were reported in patients who took the mRNA vaccines made by either Moderna or BioNTech-Pfizer.</p><p><blockquote>据报道，服用Moderna或BioNTech-Pfizer生产的mRNA疫苗的患者出现了这种情况。</blockquote></p><p> Pfizer and BioNTech are collaborating on the research and marketing of their COVID-19 vaccine. Expenses and profit from the vaccine are split equally between Pfizer and BioNTech.</p><p><blockquote>辉瑞和BioNTech正在合作研究和营销他们的新冠肺炎疫苗。疫苗的费用和利润由辉瑞和BioNTech平分。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","MRNA":"Moderna, Inc.","BNTX":"BioNTech SE"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2158325931","content_text":"BioNTech and Moderna stock rose in early trading on Thursday, on track to recover some of the previous session’s losses, following a report in the Wall Street Journal that the FDA could authorize Covid-19 booster shots for immunocompromised people.\n\nBioNTech and Moderna were up 3.96% and 2% after plunging 14% and 15.6% in the previous session, respectively. Pfizer (NYSE:PFE), which shed 4% on Wednesday, was up 1%.\nThe WSJ reported that the Food and Drug Administration is nearing a decision to authorize booster shots for people with weak immunity amid a surge in new COVID cases because of the rapid spread of the delta variant.\nThere is growing evidence that two shots of the vaccines are inadequate for people with low immunity. Vaccine makers plan to approach the FDA this month or next for approval to their booster shots.\nBioNTech, Moderna and Pfizer all closed lower Wednesday following news that Europe’s drug regulator is studying three new conditions reported by a small number of people after getting Covid-19 shots to assess if they may be possible side-effects.\nThe conditions were reported in patients who took the mRNA vaccines made by either Moderna or BioNTech-Pfizer.\nPfizer and BioNTech are collaborating on the research and marketing of their COVID-19 vaccine. Expenses and profit from the vaccine are split equally between Pfizer and BioNTech.","news_type":1,"symbols_score_info":{"PFE":0.9,"MRNA":0.9,"BNTX":0.9}},"isVote":1,"tweetType":1,"viewCount":1629,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":896402641,"gmtCreate":1628599016083,"gmtModify":1631892264511,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575416215572570","authorIdStr":"3575416215572570"},"themes":[],"htmlText":"Lose money","listText":"Lose money","text":"Lose money","images":[{"img":"https://static.tigerbbs.com/942135289525db288b1954e466ab1309","width":"1080","height":"3610"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/896402641","isVote":1,"tweetType":1,"viewCount":3577,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":896406724,"gmtCreate":1628598970368,"gmtModify":1631892264513,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575416215572570","authorIdStr":"3575416215572570"},"themes":[],"htmlText":"To the sun","listText":"To the sun","text":"To the sun","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/896406724","repostId":"1116005404","repostType":4,"repost":{"id":"1116005404","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1628582673,"share":"https://www.laohu8.com/m/news/1116005404?lang=zh_CN&edition=full","pubTime":"2021-08-10 16:04","market":"us","language":"en","title":"AMC shares rose 7% in premarket trading.<blockquote>AMC股价在盘前交易中上涨7%。</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1116005404","media":"Tiger Newspress","summary":"AMC shares rose 7% in premarket trading.\nAMC Entertainment reported a narrower than expected loss fo","content":"<p>AMC&nbsp;shares rose 7% in premarket&nbsp;trading.</p><p><blockquote>AMC股价在盘前交易中上涨7%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/692b6fc550595ea189d7b6697732bdac\" tg-width=\"854\" tg-height=\"608\" referrerpolicy=\"no-referrer\">AMC Entertainment&nbsp;reported&nbsp;a narrower than expected loss for the second quarter while revenue topped estimates.</p><p><blockquote>AMC院线公布第二季度亏损窄于预期，而营收则超出预期。</blockquote></p><p> AMC&nbsp;will begin accepting apex cryptocurrency&nbsp;<b>Bitcoin</b>&nbsp;as payment for move tickets and concessions by the end of this&nbsp;year.</p><p><blockquote>AMC将开始接受apex加密货币<b>比特币</b>作为今年年底前移动门票和优惠的付款。</blockquote></p><p> “By year end, we will have the information technology system in place to accept Bitcoin as payment for movie tickets and concessions if purchased online at all of our U.S. theatres,” AMC Entertainment CEO&nbsp;<b>Adam Aron</b>&nbsp;said on&nbsp;the Q2 earnings call on Monday.</p><p><blockquote>AMC院线首席执行官表示：“到今年年底，我们将建立信息技术系统，接受比特币作为在美国所有影院在线购买的电影票和优惠的付款方式。”<b>亚当·阿伦</b>周一在第二季度财报看涨期权上表示。</blockquote></p><p> Aron added that AMC Entertainment is in the preliminary stages of exploring how else the company can participate in the new “burgeoning cryptocurrency universe.”</p><p><blockquote>阿伦补充说，AMC院线正处于探索该公司如何参与新的“新兴加密货币世界”的初步阶段。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AMC shares rose 7% in premarket trading.<blockquote>AMC股价在盘前交易中上涨7%。</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAMC shares rose 7% in premarket trading.<blockquote>AMC股价在盘前交易中上涨7%。</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-08-10 16:04</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>AMC&nbsp;shares rose 7% in premarket&nbsp;trading.</p><p><blockquote>AMC股价在盘前交易中上涨7%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/692b6fc550595ea189d7b6697732bdac\" tg-width=\"854\" tg-height=\"608\" referrerpolicy=\"no-referrer\">AMC Entertainment&nbsp;reported&nbsp;a narrower than expected loss for the second quarter while revenue topped estimates.</p><p><blockquote>AMC院线公布第二季度亏损窄于预期，而营收则超出预期。</blockquote></p><p> AMC&nbsp;will begin accepting apex cryptocurrency&nbsp;<b>Bitcoin</b>&nbsp;as payment for move tickets and concessions by the end of this&nbsp;year.</p><p><blockquote>AMC将开始接受apex加密货币<b>比特币</b>作为今年年底前移动门票和优惠的付款。</blockquote></p><p> “By year end, we will have the information technology system in place to accept Bitcoin as payment for movie tickets and concessions if purchased online at all of our U.S. theatres,” AMC Entertainment CEO&nbsp;<b>Adam Aron</b>&nbsp;said on&nbsp;the Q2 earnings call on Monday.</p><p><blockquote>AMC院线首席执行官表示：“到今年年底，我们将建立信息技术系统，接受比特币作为在美国所有影院在线购买的电影票和优惠的付款方式。”<b>亚当·阿伦</b>周一在第二季度财报看涨期权上表示。</blockquote></p><p> Aron added that AMC Entertainment is in the preliminary stages of exploring how else the company can participate in the new “burgeoning cryptocurrency universe.”</p><p><blockquote>阿伦补充说，AMC院线正处于探索该公司如何参与新的“新兴加密货币世界”的初步阶段。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMC":"AMC院线"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1116005404","content_text":"AMC shares rose 7% in premarket trading.\nAMC Entertainment reported a narrower than expected loss for the second quarter while revenue topped estimates.\nAMC will begin accepting apex cryptocurrency Bitcoin as payment for move tickets and concessions by the end of this year.\n“By year end, we will have the information technology system in place to accept Bitcoin as payment for movie tickets and concessions if purchased online at all of our U.S. theatres,” AMC Entertainment CEO Adam Aron said on the Q2 earnings call on Monday.\nAron added that AMC Entertainment is in the preliminary stages of exploring how else the company can participate in the new “burgeoning cryptocurrency universe.”","news_type":1,"symbols_score_info":{"AMC":0.9}},"isVote":1,"tweetType":1,"viewCount":1182,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":896406617,"gmtCreate":1628598943439,"gmtModify":1631892264519,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575416215572570","authorIdStr":"3575416215572570"},"themes":[],"htmlText":"Pro","listText":"Pro","text":"Pro","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/896406617","repostId":"1122891084","repostType":4,"repost":{"id":"1122891084","kind":"news","pubTimestamp":1628585720,"share":"https://www.laohu8.com/m/news/1122891084?lang=zh_CN&edition=full","pubTime":"2021-08-10 16:55","market":"us","language":"en","title":"Moderna COVID-19 vaccine may be better than Pfizer against Delta variant; breakthrough cases rise with time<blockquote>Moderna新冠疫苗可能比辉瑞更好对抗德尔塔变异毒株；突破性案例随着时间的推移而增加</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1122891084","media":"Seeking Alpha","summary":"According to two reports published in medRxiv, the mRNA vaccine developed by Pfizer and BioNTech SE ","content":"<p><ul>  <li>According to two reports published in medRxiv, the mRNA vaccine developed by <a href=\"https://laohu8.com/S/PFE\">Pfizer</a> and <a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a>&nbsp;may be less effective than <a href=\"https://laohu8.com/S/MRNA\">Moderna, Inc.</a>'s&nbsp;against the Delta variant of the coronavirus,&nbsp;<i>Reuters reports</i>.</li>  <li>The study, yet to be peer reviewed, included more than 50,000 patients in the Mayo Clinic Health System.</li>  <li>Researchers found that efficacy of Moderna's Covid-19 vaccine dropped to 76% in July - when the Delta variant was predominant - from 86% in early 2021.</li>  <li>However, during the same time, Pfizer/BioNTech vaccine's effectiveness decreased to 42% from 76%.</li>  <li>While both vaccines remain effective at preventing Covid hospitalization, a Moderna booster shot may be necessary soon for people who got Pfizer or Moderna vaccines earlier this year, said Dr. Venky Soundararajan of Massachusetts data analytics company, who led the Mayo study.</li>  <li>In a separate study, elderly nursing home residents in Ontario produced stronger immune responses - especially against variants - after the Moderna shot than after Pfizer/BioNTech vaccine.</li>  <li>\"We continue to believe... a third dose booster may be needed within 6 to 12 months after full vaccination to maintain the highest levels of protection,\" said a Pfizer spokesperson.</li>  <li>In a study&nbsp;posted on medRxiv, it was observed that breakthrough COVID-19 odds rise months after vaccination.</li>  <li>The data suggested that people who received their second dose of the Pfizer/BioNTech vaccine five or more months ago are more likely to test positive for COVID-19 than people who were fully vaccinated less than five months ago.</li>  <li>Overall, 1.8% of individulas tested positive in a research including nearly 34,000 fully vaccinated adults in Israel which were tested to see if they had a breakthrough case of COVID-19.</li>  <li>At all ages, the odds of testing positive were higher when the last vaccine dose was received at least 146 days earlier.</li>  <li>Among patients older than 60, the odds of a positive test were almost three times higher when 146 days had passed since the second dose.</li>  <li>\"Very few patients had required hospitalization, and it is too early to assess the severity of these new infections in terms of hospital admission, need for mechanical ventilation or mortality,\" he added. \"We are planning to continue our research,\" said coauthor Dr. Eugene Merzon of Leumit Health Services in Israel.</li>  <li>Israel has already started administering booster shots to people over the age of 60.</li> </ul></p><p><blockquote><ul><li>根据medRxiv发表的两份报告，由<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>和<a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a>可能不如<a href=\"https://laohu8.com/S/MRNA\">莫德纳公司。</a>对抗冠状病毒的德尔塔变异毒株，<i>路透社报道</i>.</li><li>这项尚未经过同行评审的研究包括了梅奥诊所卫生系统的50,000多名患者。</li><li>研究人员发现，Moderna的Covid-19疫苗的效力从2021年初的86%降至7月份（当时德尔塔变异毒株占主导地位）的76%。</li><li>然而，在同一时期，辉瑞/BioNTech疫苗的有效性从76%下降到42%。</li><li>领导梅奥研究的马萨诸塞州数据分析公司的Venky Soundararajan博士说，虽然这两种疫苗在预防Covid住院方面仍然有效，但对于今年早些时候接种辉瑞或Moderna疫苗的人来说，可能很快就需要进行Moderna加强注射。</li><li>在另一项研究中，安大略省的老年疗养院居民在注射Moderna疫苗后产生了比辉瑞/BioNTech疫苗后更强的免疫反应——特别是针对变异体。</li><li>辉瑞发言人表示：“我们仍然认为……在全面接种疫苗后的6至12个月内，可能需要第三剂加强剂，以保持最高水平的保护。”</li><li>在medRxiv上发布的一项研究中，观察到接种疫苗几个月后，突破性新冠肺炎的几率会上升。</li><li>数据表明，五个月或更长时间前接种第二剂辉瑞/BioNTech疫苗的人比不到五个月前完全接种疫苗的人更有可能检测出新冠肺炎阳性。</li><li>总体而言，在一项研究中，1.8%的人检测呈阳性，该研究包括以色列近34,000名完全接种疫苗的成年人，他们接受了检测，看看他们是否有突破性的新冠肺炎病例。</li><li>在所有年龄段，当最后一剂疫苗至少提前146天接种时，检测呈阳性的几率较高。</li><li>在60岁以上的患者中，自第二次注射后146天，检测呈阳性的几率几乎高出三倍。</li><li>他补充说：“很少有患者需要住院治疗，现在从住院、机械通气需求或死亡率方面评估这些新感染的严重程度还为时过早。”“我们计划继续我们的研究，”以色列Leumit Health Services的合著者Eugene Merzon博士说。</li><li>以色列已经开始对60岁以上的人进行加强注射。</li></ul></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna COVID-19 vaccine may be better than Pfizer against Delta variant; breakthrough cases rise with time<blockquote>Moderna新冠疫苗可能比辉瑞更好对抗德尔塔变异毒株；突破性案例随着时间的推移而增加</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna COVID-19 vaccine may be better than Pfizer against Delta variant; breakthrough cases rise with time<blockquote>Moderna新冠疫苗可能比辉瑞更好对抗德尔塔变异毒株；突破性案例随着时间的推移而增加</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Seeking Alpha</strong><span class=\"h-time small\">2021-08-10 16:55</span>\n</p>\n</h4>\n</header>\n<article>\n<p><ul>  <li>According to two reports published in medRxiv, the mRNA vaccine developed by <a href=\"https://laohu8.com/S/PFE\">Pfizer</a> and <a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a>&nbsp;may be less effective than <a href=\"https://laohu8.com/S/MRNA\">Moderna, Inc.</a>'s&nbsp;against the Delta variant of the coronavirus,&nbsp;<i>Reuters reports</i>.</li>  <li>The study, yet to be peer reviewed, included more than 50,000 patients in the Mayo Clinic Health System.</li>  <li>Researchers found that efficacy of Moderna's Covid-19 vaccine dropped to 76% in July - when the Delta variant was predominant - from 86% in early 2021.</li>  <li>However, during the same time, Pfizer/BioNTech vaccine's effectiveness decreased to 42% from 76%.</li>  <li>While both vaccines remain effective at preventing Covid hospitalization, a Moderna booster shot may be necessary soon for people who got Pfizer or Moderna vaccines earlier this year, said Dr. Venky Soundararajan of Massachusetts data analytics company, who led the Mayo study.</li>  <li>In a separate study, elderly nursing home residents in Ontario produced stronger immune responses - especially against variants - after the Moderna shot than after Pfizer/BioNTech vaccine.</li>  <li>\"We continue to believe... a third dose booster may be needed within 6 to 12 months after full vaccination to maintain the highest levels of protection,\" said a Pfizer spokesperson.</li>  <li>In a study&nbsp;posted on medRxiv, it was observed that breakthrough COVID-19 odds rise months after vaccination.</li>  <li>The data suggested that people who received their second dose of the Pfizer/BioNTech vaccine five or more months ago are more likely to test positive for COVID-19 than people who were fully vaccinated less than five months ago.</li>  <li>Overall, 1.8% of individulas tested positive in a research including nearly 34,000 fully vaccinated adults in Israel which were tested to see if they had a breakthrough case of COVID-19.</li>  <li>At all ages, the odds of testing positive were higher when the last vaccine dose was received at least 146 days earlier.</li>  <li>Among patients older than 60, the odds of a positive test were almost three times higher when 146 days had passed since the second dose.</li>  <li>\"Very few patients had required hospitalization, and it is too early to assess the severity of these new infections in terms of hospital admission, need for mechanical ventilation or mortality,\" he added. \"We are planning to continue our research,\" said coauthor Dr. Eugene Merzon of Leumit Health Services in Israel.</li>  <li>Israel has already started administering booster shots to people over the age of 60.</li> </ul></p><p><blockquote><ul><li>根据medRxiv发表的两份报告，由<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>和<a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a>可能不如<a href=\"https://laohu8.com/S/MRNA\">莫德纳公司。</a>对抗冠状病毒的德尔塔变异毒株，<i>路透社报道</i>.</li><li>这项尚未经过同行评审的研究包括了梅奥诊所卫生系统的50,000多名患者。</li><li>研究人员发现，Moderna的Covid-19疫苗的效力从2021年初的86%降至7月份（当时德尔塔变异毒株占主导地位）的76%。</li><li>然而，在同一时期，辉瑞/BioNTech疫苗的有效性从76%下降到42%。</li><li>领导梅奥研究的马萨诸塞州数据分析公司的Venky Soundararajan博士说，虽然这两种疫苗在预防Covid住院方面仍然有效，但对于今年早些时候接种辉瑞或Moderna疫苗的人来说，可能很快就需要进行Moderna加强注射。</li><li>在另一项研究中，安大略省的老年疗养院居民在注射Moderna疫苗后产生了比辉瑞/BioNTech疫苗后更强的免疫反应——特别是针对变异体。</li><li>辉瑞发言人表示：“我们仍然认为……在全面接种疫苗后的6至12个月内，可能需要第三剂加强剂，以保持最高水平的保护。”</li><li>在medRxiv上发布的一项研究中，观察到接种疫苗几个月后，突破性新冠肺炎的几率会上升。</li><li>数据表明，五个月或更长时间前接种第二剂辉瑞/BioNTech疫苗的人比不到五个月前完全接种疫苗的人更有可能检测出新冠肺炎阳性。</li><li>总体而言，在一项研究中，1.8%的人检测呈阳性，该研究包括以色列近34,000名完全接种疫苗的成年人，他们接受了检测，看看他们是否有突破性的新冠肺炎病例。</li><li>在所有年龄段，当最后一剂疫苗至少提前146天接种时，检测呈阳性的几率较高。</li><li>在60岁以上的患者中，自第二次注射后146天，检测呈阳性的几率几乎高出三倍。</li><li>他补充说：“很少有患者需要住院治疗，现在从住院、机械通气需求或死亡率方面评估这些新感染的严重程度还为时过早。”“我们计划继续我们的研究，”以色列Leumit Health Services的合著者Eugene Merzon博士说。</li><li>以色列已经开始对60岁以上的人进行加强注射。</li></ul></blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://seekingalpha.com/news/3727988-moderna-covid-19-vaccine-may-be-better-than-pfizer-against-delta-variant-breakthrough-cases-rise-with-time\">Seeking Alpha</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc.","BNTX":"BioNTech SE","PFE":"辉瑞"},"source_url":"https://seekingalpha.com/news/3727988-moderna-covid-19-vaccine-may-be-better-than-pfizer-against-delta-variant-breakthrough-cases-rise-with-time","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1122891084","content_text":"According to two reports published in medRxiv, the mRNA vaccine developed by Pfizer and BioNTech SE may be less effective than Moderna, Inc.'s against the Delta variant of the coronavirus, Reuters reports.\nThe study, yet to be peer reviewed, included more than 50,000 patients in the Mayo Clinic Health System.\nResearchers found that efficacy of Moderna's Covid-19 vaccine dropped to 76% in July - when the Delta variant was predominant - from 86% in early 2021.\nHowever, during the same time, Pfizer/BioNTech vaccine's effectiveness decreased to 42% from 76%.\nWhile both vaccines remain effective at preventing Covid hospitalization, a Moderna booster shot may be necessary soon for people who got Pfizer or Moderna vaccines earlier this year, said Dr. Venky Soundararajan of Massachusetts data analytics company, who led the Mayo study.\nIn a separate study, elderly nursing home residents in Ontario produced stronger immune responses - especially against variants - after the Moderna shot than after Pfizer/BioNTech vaccine.\n\"We continue to believe... a third dose booster may be needed within 6 to 12 months after full vaccination to maintain the highest levels of protection,\" said a Pfizer spokesperson.\nIn a study posted on medRxiv, it was observed that breakthrough COVID-19 odds rise months after vaccination.\nThe data suggested that people who received their second dose of the Pfizer/BioNTech vaccine five or more months ago are more likely to test positive for COVID-19 than people who were fully vaccinated less than five months ago.\nOverall, 1.8% of individulas tested positive in a research including nearly 34,000 fully vaccinated adults in Israel which were tested to see if they had a breakthrough case of COVID-19.\nAt all ages, the odds of testing positive were higher when the last vaccine dose was received at least 146 days earlier.\nAmong patients older than 60, the odds of a positive test were almost three times higher when 146 days had passed since the second dose.\n\"Very few patients had required hospitalization, and it is too early to assess the severity of these new infections in terms of hospital admission, need for mechanical ventilation or mortality,\" he added. \"We are planning to continue our research,\" said coauthor Dr. Eugene Merzon of Leumit Health Services in Israel.\nIsrael has already started administering booster shots to people over the age of 60.","news_type":1,"symbols_score_info":{"PFE":0.9,"MRNA":0.9,"BNTX":0.9}},"isVote":1,"tweetType":1,"viewCount":3479,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":893119227,"gmtCreate":1628245138469,"gmtModify":1631892264522,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575416215572570","authorIdStr":"3575416215572570"},"themes":[],"htmlText":"All the way","listText":"All the way","text":"All the way","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/893119227","repostId":"1135651416","repostType":4,"isVote":1,"tweetType":1,"viewCount":1749,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":806534198,"gmtCreate":1627666751414,"gmtModify":1631892264524,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575416215572570","authorIdStr":"3575416215572570"},"themes":[],"htmlText":"To the sun","listText":"To the sun","text":"To the sun","images":[{"img":"https://static.tigerbbs.com/edc1f1e47b16e96a42d7ec21bf988e3c","width":"1080","height":"3691"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/806534198","isVote":1,"tweetType":1,"viewCount":3298,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":808042660,"gmtCreate":1627547020950,"gmtModify":1631884531690,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575416215572570","authorIdStr":"3575416215572570"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/EBON\">$Ebang International Holdings Inc.(EBON)$</a>not meant to be","listText":"<a href=\"https://laohu8.com/S/EBON\">$Ebang International Holdings Inc.(EBON)$</a>not meant to be","text":"$Ebang International Holdings Inc.(EBON)$not meant to be","images":[{"img":"https://static.tigerbbs.com/481041af7db4ea49f66170c2f8001a68","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/808042660","isVote":1,"tweetType":1,"viewCount":3055,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":175423584,"gmtCreate":1627047386448,"gmtModify":1631892264526,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575416215572570","authorIdStr":"3575416215572570"},"themes":[],"htmlText":"Trash stock","listText":"Trash stock","text":"Trash stock","images":[{"img":"https://static.tigerbbs.com/c2a7977bbebb8a789f10da9a7ff17a88","width":"1080","height":"3691"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/175423584","isVote":1,"tweetType":1,"viewCount":3165,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":175429165,"gmtCreate":1627047351657,"gmtModify":1631892264530,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575416215572570","authorIdStr":"3575416215572570"},"themes":[],"htmlText":"To the moon","listText":"To the moon","text":"To the moon","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/175429165","repostId":"2153498346","repostType":4,"isVote":1,"tweetType":1,"viewCount":4136,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":176634432,"gmtCreate":1626879223426,"gmtModify":1631892264531,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575416215572570","authorIdStr":"3575416215572570"},"themes":[],"htmlText":"Unreasonable","listText":"Unreasonable","text":"Unreasonable","images":[{"img":"https://static.tigerbbs.com/c47f8c09fbac996a5bad78b0075ac046","width":"1080","height":"3691"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/176634432","isVote":1,"tweetType":1,"viewCount":534,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":179393598,"gmtCreate":1626485012014,"gmtModify":1633926368266,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575416215572570","authorIdStr":"3575416215572570"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/GOTU\">$Gaotu Techedu Inc.(GOTU)$</a>omg. Trash stock","listText":"<a href=\"https://laohu8.com/S/GOTU\">$Gaotu Techedu Inc.(GOTU)$</a>omg. Trash stock","text":"$Gaotu Techedu Inc.(GOTU)$omg. Trash stock","images":[{"img":"https://static.tigerbbs.com/6c28595f6d5a7673fb76b17b1c6320fd","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/179393598","isVote":1,"tweetType":1,"viewCount":1496,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":147822526,"gmtCreate":1626351695365,"gmtModify":1633927630673,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575416215572570","authorIdStr":"3575416215572570"},"themes":[],"htmlText":"Up the lorry&nbsp;","listText":"Up the lorry&nbsp;","text":"Up the lorry","images":[{"img":"https://static.tigerbbs.com/7d195ba504666aa9c1d493e565d9fa90","width":"1080","height":"3571"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/147822526","isVote":1,"tweetType":1,"viewCount":639,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":147822270,"gmtCreate":1626351668090,"gmtModify":1633927630795,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575416215572570","authorIdStr":"3575416215572570"},"themes":[],"htmlText":"All the way","listText":"All the way","text":"All the way","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/147822270","repostId":"2151251345","repostType":4,"repost":{"id":"2151251345","kind":"highlight","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1626343025,"share":"https://www.laohu8.com/m/news/2151251345?lang=zh_CN&edition=full","pubTime":"2021-07-15 17:57","market":"us","language":"en","title":"UnitedHealth Group Q2 EPS $4.70 Beats $4.43 Estimate, Sales $71.30B Beat $69.45B Estimate<blockquote>联合健康集团第二季度EPS$4.70超出预期$4.43，销售额$71.30 B超出预期$69.45 B</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=2151251345","media":"Benzinga","summary":"UnitedHealth Group (NYSE:UNH) reported quarterly earnings of $4.70 per share which beat the analyst consensus estimate of $4.43 by 6.09 percent. This is a 33.99 percent decrease over earnings of $7.12 per share from the","content":"<p>UnitedHealth Group Inc beat quarterly profit estimates and raised its full-year earnings target on Thursday, as the largest U.S. health insurer reported strong growth in its Optum unit that manages drug benefits.</p><p><blockquote>美国最大的健康保险公司联合健康集团(UnitedHealth Group Inc)周四公布其管理药品福利的Optum部门强劲增长，超出了季度利润预期，并上调了全年盈利目标。</blockquote></p><p> The industry bellwether raised its full-year profit target for the second time this year, and now expects adjusted earnings of $18.30 to $18.80 per share in 2021, compared with its previous forecast of $18.10 to $18.60.</p><p><blockquote>这家行业领头羊今年第二次上调全年利润目标，目前预计2021年调整后每股收益为18.30美元至18.80美元，此前预期为18.10美元至18.60美元。</blockquote></p><p> For the quarter ended June 30, the company reported a medical loss ratio - the percentage of collected premiums spent on medical services - of 82.8%, compared with 70.2% a year earlier, when patients put off non-urgent care due to the COVID-19 pandemic.</p><p><blockquote>截至6月30日的季度，该公司报告的医疗损失率（收取的保费用于医疗服务的百分比）为82.8%，而去年同期为70.2%，当时患者因COVID-19而推迟了非紧急护理-19大流行。</blockquote></p><p> Nearly half of all Americans have been fully vaccinated according to latest government data and daily new COVID-19 cases ebbed in May and June, encouraging people to return to doctors' offices for routine, non-elective medical care.</p><p><blockquote>根据最新的政府数据，近一半的美国人已完全接种疫苗，5月和6月每日新增COVID-19病例有所减少，这鼓励人们返回医生办公室接受常规的非选择性医疗护理。</blockquote></p><p> Revenue from UnitedHealth's Optum unit, which manages drug benefits and offers healthcare data analytics services, rose 17.2% to $38.3 billion from a year earlier.</p><p><blockquote>UnitedHealth旗下Optum部门负责管理药物福利并提供医疗保健数据分析服务，其收入同比增长17.2%，达到383亿美元。</blockquote></p><p> UnitedHealth reported adjusted earnings of $4.70 per share, beating estimates of $4.43 per share, according to IBES data from Refinitiv.</p><p><blockquote>根据Refinitiv的IBES数据，联合健康报告调整后每股收益为4.70美元，超出预期的每股4.43美元。</blockquote></p><p> The company has beaten Wall Street's expectations for earnings per share for at least the last eight quarters.</p><p><blockquote>该公司至少在过去八个季度的每股收益超出了华尔街的预期。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>UnitedHealth Group Q2 EPS $4.70 Beats $4.43 Estimate, Sales $71.30B Beat $69.45B Estimate<blockquote>联合健康集团第二季度EPS$4.70超出预期$4.43，销售额$71.30 B超出预期$69.45 B</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUnitedHealth Group Q2 EPS $4.70 Beats $4.43 Estimate, Sales $71.30B Beat $69.45B Estimate<blockquote>联合健康集团第二季度EPS$4.70超出预期$4.43，销售额$71.30 B超出预期$69.45 B</blockquote>\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time smaller\">2021-07-15 17:57</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<p>UnitedHealth Group Inc beat quarterly profit estimates and raised its full-year earnings target on Thursday, as the largest U.S. health insurer reported strong growth in its Optum unit that manages drug benefits.</p><p><blockquote>美国最大的健康保险公司联合健康集团(UnitedHealth Group Inc)周四公布其管理药品福利的Optum部门强劲增长，超出了季度利润预期，并上调了全年盈利目标。</blockquote></p><p> The industry bellwether raised its full-year profit target for the second time this year, and now expects adjusted earnings of $18.30 to $18.80 per share in 2021, compared with its previous forecast of $18.10 to $18.60.</p><p><blockquote>这家行业领头羊今年第二次上调全年利润目标，目前预计2021年调整后每股收益为18.30美元至18.80美元，此前预期为18.10美元至18.60美元。</blockquote></p><p> For the quarter ended June 30, the company reported a medical loss ratio - the percentage of collected premiums spent on medical services - of 82.8%, compared with 70.2% a year earlier, when patients put off non-urgent care due to the COVID-19 pandemic.</p><p><blockquote>截至6月30日的季度，该公司报告的医疗损失率（收取的保费用于医疗服务的百分比）为82.8%，而去年同期为70.2%，当时患者因COVID-19而推迟了非紧急护理-19大流行。</blockquote></p><p> Nearly half of all Americans have been fully vaccinated according to latest government data and daily new COVID-19 cases ebbed in May and June, encouraging people to return to doctors' offices for routine, non-elective medical care.</p><p><blockquote>根据最新的政府数据，近一半的美国人已完全接种疫苗，5月和6月每日新增COVID-19病例有所减少，这鼓励人们返回医生办公室接受常规的非选择性医疗护理。</blockquote></p><p> Revenue from UnitedHealth's Optum unit, which manages drug benefits and offers healthcare data analytics services, rose 17.2% to $38.3 billion from a year earlier.</p><p><blockquote>UnitedHealth旗下Optum部门负责管理药物福利并提供医疗保健数据分析服务，其收入同比增长17.2%，达到383亿美元。</blockquote></p><p> UnitedHealth reported adjusted earnings of $4.70 per share, beating estimates of $4.43 per share, according to IBES data from Refinitiv.</p><p><blockquote>根据Refinitiv的IBES数据，联合健康报告调整后每股收益为4.70美元，超出预期的每股4.43美元。</blockquote></p><p> The company has beaten Wall Street's expectations for earnings per share for at least the last eight quarters.</p><p><blockquote>该公司至少在过去八个季度的每股收益超出了华尔街的预期。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"UNH":"联合健康","QTWO":"Q2 Holdings Inc"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2151251345","content_text":"UnitedHealth Group Inc beat quarterly profit estimates and raised its full-year earnings target on Thursday, as the largest U.S. health insurer reported strong growth in its Optum unit that manages drug benefits.\nThe industry bellwether raised its full-year profit target for the second time this year, and now expects adjusted earnings of $18.30 to $18.80 per share in 2021, compared with its previous forecast of $18.10 to $18.60.\nFor the quarter ended June 30, the company reported a medical loss ratio - the percentage of collected premiums spent on medical services - of 82.8%, compared with 70.2% a year earlier, when patients put off non-urgent care due to the COVID-19 pandemic.\nNearly half of all Americans have been fully vaccinated according to latest government data and daily new COVID-19 cases ebbed in May and June, encouraging people to return to doctors' offices for routine, non-elective medical care.\nRevenue from UnitedHealth's Optum unit, which manages drug benefits and offers healthcare data analytics services, rose 17.2% to $38.3 billion from a year earlier.\nUnitedHealth reported adjusted earnings of $4.70 per share, beating estimates of $4.43 per share, according to IBES data from Refinitiv.\nThe company has beaten Wall Street's expectations for earnings per share for at least the last eight quarters.","news_type":1,"symbols_score_info":{"QTWO":0.9,"UNH":0.9}},"isVote":1,"tweetType":1,"viewCount":483,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":147822126,"gmtCreate":1626351647465,"gmtModify":1633927631162,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575416215572570","authorIdStr":"3575416215572570"},"themes":[],"htmlText":"All the way down","listText":"All the way down","text":"All the way down","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/147822126","repostId":"2151251345","repostType":4,"repost":{"id":"2151251345","kind":"highlight","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1626343025,"share":"https://www.laohu8.com/m/news/2151251345?lang=zh_CN&edition=full","pubTime":"2021-07-15 17:57","market":"us","language":"en","title":"UnitedHealth Group Q2 EPS $4.70 Beats $4.43 Estimate, Sales $71.30B Beat $69.45B Estimate<blockquote>联合健康集团第二季度EPS$4.70超出预期$4.43，销售额$71.30 B超出预期$69.45 B</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=2151251345","media":"Benzinga","summary":"UnitedHealth Group (NYSE:UNH) reported quarterly earnings of $4.70 per share which beat the analyst consensus estimate of $4.43 by 6.09 percent. This is a 33.99 percent decrease over earnings of $7.12 per share from the","content":"<p>UnitedHealth Group Inc beat quarterly profit estimates and raised its full-year earnings target on Thursday, as the largest U.S. health insurer reported strong growth in its Optum unit that manages drug benefits.</p><p><blockquote>美国最大的健康保险公司联合健康集团(UnitedHealth Group Inc)周四公布其管理药品福利的Optum部门强劲增长，超出了季度利润预期，并上调了全年盈利目标。</blockquote></p><p> The industry bellwether raised its full-year profit target for the second time this year, and now expects adjusted earnings of $18.30 to $18.80 per share in 2021, compared with its previous forecast of $18.10 to $18.60.</p><p><blockquote>这家行业领头羊今年第二次上调全年利润目标，目前预计2021年调整后每股收益为18.30美元至18.80美元，此前预期为18.10美元至18.60美元。</blockquote></p><p> For the quarter ended June 30, the company reported a medical loss ratio - the percentage of collected premiums spent on medical services - of 82.8%, compared with 70.2% a year earlier, when patients put off non-urgent care due to the COVID-19 pandemic.</p><p><blockquote>截至6月30日的季度，该公司报告的医疗损失率（收取的保费用于医疗服务的百分比）为82.8%，而去年同期为70.2%，当时患者因COVID-19而推迟了非紧急护理-19大流行。</blockquote></p><p> Nearly half of all Americans have been fully vaccinated according to latest government data and daily new COVID-19 cases ebbed in May and June, encouraging people to return to doctors' offices for routine, non-elective medical care.</p><p><blockquote>根据最新的政府数据，近一半的美国人已完全接种疫苗，5月和6月每日新增COVID-19病例有所减少，这鼓励人们返回医生办公室接受常规的非选择性医疗护理。</blockquote></p><p> Revenue from UnitedHealth's Optum unit, which manages drug benefits and offers healthcare data analytics services, rose 17.2% to $38.3 billion from a year earlier.</p><p><blockquote>UnitedHealth旗下Optum部门负责管理药物福利并提供医疗保健数据分析服务，其收入同比增长17.2%，达到383亿美元。</blockquote></p><p> UnitedHealth reported adjusted earnings of $4.70 per share, beating estimates of $4.43 per share, according to IBES data from Refinitiv.</p><p><blockquote>根据Refinitiv的IBES数据，联合健康报告调整后每股收益为4.70美元，超出预期的每股4.43美元。</blockquote></p><p> The company has beaten Wall Street's expectations for earnings per share for at least the last eight quarters.</p><p><blockquote>该公司至少在过去八个季度的每股收益超出了华尔街的预期。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>UnitedHealth Group Q2 EPS $4.70 Beats $4.43 Estimate, Sales $71.30B Beat $69.45B Estimate<blockquote>联合健康集团第二季度EPS$4.70超出预期$4.43，销售额$71.30 B超出预期$69.45 B</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUnitedHealth Group Q2 EPS $4.70 Beats $4.43 Estimate, Sales $71.30B Beat $69.45B Estimate<blockquote>联合健康集团第二季度EPS$4.70超出预期$4.43，销售额$71.30 B超出预期$69.45 B</blockquote>\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time smaller\">2021-07-15 17:57</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<p>UnitedHealth Group Inc beat quarterly profit estimates and raised its full-year earnings target on Thursday, as the largest U.S. health insurer reported strong growth in its Optum unit that manages drug benefits.</p><p><blockquote>美国最大的健康保险公司联合健康集团(UnitedHealth Group Inc)周四公布其管理药品福利的Optum部门强劲增长，超出了季度利润预期，并上调了全年盈利目标。</blockquote></p><p> The industry bellwether raised its full-year profit target for the second time this year, and now expects adjusted earnings of $18.30 to $18.80 per share in 2021, compared with its previous forecast of $18.10 to $18.60.</p><p><blockquote>这家行业领头羊今年第二次上调全年利润目标，目前预计2021年调整后每股收益为18.30美元至18.80美元，此前预期为18.10美元至18.60美元。</blockquote></p><p> For the quarter ended June 30, the company reported a medical loss ratio - the percentage of collected premiums spent on medical services - of 82.8%, compared with 70.2% a year earlier, when patients put off non-urgent care due to the COVID-19 pandemic.</p><p><blockquote>截至6月30日的季度，该公司报告的医疗损失率（收取的保费用于医疗服务的百分比）为82.8%，而去年同期为70.2%，当时患者因COVID-19而推迟了非紧急护理-19大流行。</blockquote></p><p> Nearly half of all Americans have been fully vaccinated according to latest government data and daily new COVID-19 cases ebbed in May and June, encouraging people to return to doctors' offices for routine, non-elective medical care.</p><p><blockquote>根据最新的政府数据，近一半的美国人已完全接种疫苗，5月和6月每日新增COVID-19病例有所减少，这鼓励人们返回医生办公室接受常规的非选择性医疗护理。</blockquote></p><p> Revenue from UnitedHealth's Optum unit, which manages drug benefits and offers healthcare data analytics services, rose 17.2% to $38.3 billion from a year earlier.</p><p><blockquote>UnitedHealth旗下Optum部门负责管理药物福利并提供医疗保健数据分析服务，其收入同比增长17.2%，达到383亿美元。</blockquote></p><p> UnitedHealth reported adjusted earnings of $4.70 per share, beating estimates of $4.43 per share, according to IBES data from Refinitiv.</p><p><blockquote>根据Refinitiv的IBES数据，联合健康报告调整后每股收益为4.70美元，超出预期的每股4.43美元。</blockquote></p><p> The company has beaten Wall Street's expectations for earnings per share for at least the last eight quarters.</p><p><blockquote>该公司至少在过去八个季度的每股收益超出了华尔街的预期。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"UNH":"联合健康","QTWO":"Q2 Holdings Inc"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2151251345","content_text":"UnitedHealth Group Inc beat quarterly profit estimates and raised its full-year earnings target on Thursday, as the largest U.S. health insurer reported strong growth in its Optum unit that manages drug benefits.\nThe industry bellwether raised its full-year profit target for the second time this year, and now expects adjusted earnings of $18.30 to $18.80 per share in 2021, compared with its previous forecast of $18.10 to $18.60.\nFor the quarter ended June 30, the company reported a medical loss ratio - the percentage of collected premiums spent on medical services - of 82.8%, compared with 70.2% a year earlier, when patients put off non-urgent care due to the COVID-19 pandemic.\nNearly half of all Americans have been fully vaccinated according to latest government data and daily new COVID-19 cases ebbed in May and June, encouraging people to return to doctors' offices for routine, non-elective medical care.\nRevenue from UnitedHealth's Optum unit, which manages drug benefits and offers healthcare data analytics services, rose 17.2% to $38.3 billion from a year earlier.\nUnitedHealth reported adjusted earnings of $4.70 per share, beating estimates of $4.43 per share, according to IBES data from Refinitiv.\nThe company has beaten Wall Street's expectations for earnings per share for at least the last eight quarters.","news_type":1,"symbols_score_info":{"QTWO":0.9,"UNH":0.9}},"isVote":1,"tweetType":1,"viewCount":558,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":146539505,"gmtCreate":1626089102907,"gmtModify":1631884663863,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575416215572570","authorIdStr":"3575416215572570"},"themes":[],"htmlText":"Slowly but surely. Target $18","listText":"Slowly but surely. Target $18","text":"Slowly but surely. Target $18","images":[{"img":"https://static.tigerbbs.com/6bc509e907310e577e7b32e0d7f1bb08","width":"1080","height":"3472"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/146539505","isVote":1,"tweetType":1,"viewCount":617,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":146530565,"gmtCreate":1626089052357,"gmtModify":1633930280406,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575416215572570","authorIdStr":"3575416215572570"},"themes":[],"htmlText":"Wow this&nbsp;","listText":"Wow this&nbsp;","text":"Wow this","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/146530565","repostId":"2150538413","repostType":4,"isVote":1,"tweetType":1,"viewCount":540,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":146530690,"gmtCreate":1626089026910,"gmtModify":1633930280528,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575416215572570","authorIdStr":"3575416215572570"},"themes":[],"htmlText":"Good read","listText":"Good read","text":"Good read","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/146530690","repostId":"1114863871","repostType":4,"isVote":1,"tweetType":1,"viewCount":701,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":141549674,"gmtCreate":1625882430398,"gmtModify":1633936445925,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575416215572570","authorIdStr":"3575416215572570"},"themes":[],"htmlText":"All the way","listText":"All the way","text":"All the way","images":[{"img":"https://static.tigerbbs.com/72bbe6a315f54d7217be8dba61768a24","width":"1080","height":"3571"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/141549674","isVote":1,"tweetType":1,"viewCount":665,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":141540425,"gmtCreate":1625882401567,"gmtModify":1633936446741,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575416215572570","authorIdStr":"3575416215572570"},"themes":[],"htmlText":"Lets go","listText":"Lets go","text":"Lets go","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/141540425","repostId":"2150305430","repostType":4,"isVote":1,"tweetType":1,"viewCount":594,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":359501806,"gmtCreate":1616408868405,"gmtModify":1634526005744,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3575416215572570","idStr":"3575416215572570"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/GME\">$GameStop(GME)$</a>diamond hand here","listText":"<a href=\"https://laohu8.com/S/GME\">$GameStop(GME)$</a>diamond hand here","text":"$GameStop(GME)$diamond hand here","images":[{"img":"https://static.tigerbbs.com/f1d3f5f8e935639ce808309299a869c8","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":5,"repostSize":0,"link":"https://laohu8.com/post/359501806","isVote":1,"tweetType":1,"viewCount":1661,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3499891542239139","authorId":"3499891542239139","name":"小小虎儿儿","avatar":"https://static.tigerbbs.com/80d9d31f798bff492018b73985e9b525","crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"3499891542239139","idStr":"3499891542239139"},"content":"💎👋是什么意思？","text":"💎👋是什么意思？","html":"💎👋是什么意思？"}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":179393598,"gmtCreate":1626485012014,"gmtModify":1633926368266,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3575416215572570","idStr":"3575416215572570"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/GOTU\">$Gaotu Techedu Inc.(GOTU)$</a>omg. Trash stock","listText":"<a href=\"https://laohu8.com/S/GOTU\">$Gaotu Techedu Inc.(GOTU)$</a>omg. Trash stock","text":"$Gaotu Techedu Inc.(GOTU)$omg. Trash stock","images":[{"img":"https://static.tigerbbs.com/6c28595f6d5a7673fb76b17b1c6320fd","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/179393598","isVote":1,"tweetType":1,"viewCount":1496,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":323792151,"gmtCreate":1615373252973,"gmtModify":1703488053322,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3575416215572570","idStr":"3575416215572570"},"themes":[],"htmlText":"Go higher higher","listText":"Go higher higher","text":"Go higher higher","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/323792151","repostId":"1162030727","repostType":4,"repost":{"id":"1162030727","kind":"news","pubTimestamp":1615371076,"share":"https://www.laohu8.com/m/news/1162030727?lang=zh_CN&edition=full","pubTime":"2021-03-10 18:11","market":"us","language":"en","title":"The Equity-Gold Price Conundrum, Part 1: The Great Batsby<blockquote>股票-黄金价格难题，第1部分：伟大的蝙蝠侠</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1162030727","media":"zerohedge","summary":"The relentless rally in equity markets has pushed valuations to extreme levels based on traditional ","content":"<p>The relentless rally in equity markets has pushed valuations to extreme levels based on traditional metrics. In this report, we analyze the two common arguments made by equity bulls on why this time is different and current valuations are justified. We find that either gold or equities are currently mispriced, as, a) both arguments would imply that gold should outperform stocks and b) if neither of the scenarios play out, equities are due for a substantial correction.</p><p><blockquote>根据传统指标，股市的持续上涨已将估值推至极端水平。在本报告中，我们分析了股票多头提出的两个常见论点，即为什么这次不同以及当前估值是合理的。我们发现，黄金或股票目前的定价都是错误的，因为a)这两种论点都意味着黄金的表现应该优于股票，b)如果这两种情况都没有发生，股票将出现大幅调整。</blockquote></p><p><img src=\"https://static.tigerbbs.com/95f7609bf84bf26bd5d2443fa9a7de86\" tg-width=\"500\" tg-height=\"445\" referrerpolicy=\"no-referrer\">Amidst the global COVID-19 pandemic, equities had staggering rally over the past 12 months. The S&amp;P500 almost doubled in less than a year from a low of 2240 on March 23, 2020 to currently 3860 at the time of writing. In addition, some narrower indices have done even better. Particularly certain technology stocks have relentlessly risen amidst an environment of economic stress.</p><p><blockquote>在全球新冠肺炎疫情中，股市在过去12个月中出现了惊人的反弹。标准普尔500指数在不到一年的时间里几乎翻了一番，从2020年3月23日的低点2240点升至撰写本文时目前的3860点。此外，一些较窄的指数表现甚至更好。尤其是某些科技股在经济压力的环境下持续上涨。</blockquote></p><p>This has led to a sharp increase in the equities-to-gold price ratio (see Exhibit 1) even as economic growth has collapsed while the Fed increased its balance sheet at an unprecedented level.</p><p><blockquote>这导致股票与黄金的价格比率急剧上升（见图表1），尽管经济增长已经崩溃，而美联储以前所未有的水平增加了资产负债表。</blockquote></p><p><img src=\"https://static.tigerbbs.com/a828b10b92375dfb19347e6c59314c83\" tg-width=\"500\" tg-height=\"405\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p>This increase in the equities-to-gold-ratio is not caused by gold performing poorly as prices for the yellow metal are up12% since the end of 2019. It’s simply a consequence of equities’ doing really well. But equity valuations according to traditional metrics have now approached extreme levels. For example, the total market cap to GDP (Buffet indicator) is currently at 193% (see exhibit 2), the highest on record, 50% above the peak during the dot.com bubble.</p><p><blockquote>股票与黄金比率的上升并不是由黄金表现不佳造成的，因为自2019年底以来，黄金价格上涨了12%。这只是股市表现良好的结果。但根据传统指标，股票估值现已接近极端水平。例如，总市值占GDP（巴菲特指标）目前为193%（见图表2），为有记录以来的最高水平，比互联网泡沫期间的峰值高出50%。</blockquote></p><p><img src=\"https://static.tigerbbs.com/e64899d2c53b18cc97b2dce33717c9af\" tg-width=\"500\" tg-height=\"428\" referrerpolicy=\"no-referrer\">Moreover, global equities to GDP are also extremely high, currently at &gt;120% (see exhibit 3).</p><p><blockquote>此外，全球股票占GDP的比例也极高，目前超过120%（见图表3）。</blockquote></p><p><img src=\"https://static.tigerbbs.com/ef426becc1777204ae2f18e3c290e2e6\" tg-width=\"500\" tg-height=\"436\" referrerpolicy=\"no-referrer\">The Cyclically Adjusted Price Earnings Ratio, or CAPE, a measure developed by Robert Schiller, is also flashing red with the second highest reading in history going back to the late 1900s (see exhibit 4).</p><p><blockquote>周期性调整市盈率（CAPE）是罗伯特·席勒（Robert Schiller）开发的一种衡量标准，也呈红色，其读数是自1900年代末以来历史上第二高的读数（见图表4）。</blockquote></p><p><img src=\"https://static.tigerbbs.com/8cc92db52653acc17b59de9311c17bf0\" tg-width=\"500\" tg-height=\"442\" referrerpolicy=\"no-referrer\">Price to sales ratios also hit a record high (see Exhibit 5).</p><p><blockquote>市销率也创下历史新高（见图表5）。</blockquote></p><p><img src=\"https://static.tigerbbs.com/a119fa360112d18ced5d8efff557ebea\" tg-width=\"500\" tg-height=\"436\" referrerpolicy=\"no-referrer\">There are other indicators that suggest that equity prices have detached from underlying fundamentals. The put / call ratio on the CBOE has now reached the levels of the dot.com bubble (see Exhibit 6).</p><p><blockquote>还有其他指标表明股价已经脱离了基本面。芝加哥期权交易所的看跌/看涨期权比率现在已经达到了互联网泡沫的水平（见图表6）。</blockquote></p><p><img src=\"https://static.tigerbbs.com/462aa5d4dee82e50792b2a4f6bbd70f8\" tg-width=\"500\" tg-height=\"389\" referrerpolicy=\"no-referrer\">We also saw an unprecedented inflow of new market participants. People with very little or no market exp4erience opened online brokerage accounts at an unprecedented speed during the global lockdowns. More than 10 million Americans opened a trading account in 2020 according to the Wall Street Journal.&nbsp; According to CNBC, ten percent of Americans bought a stock for the first time in the past 12 months, and a staggering twenty-two percent of Gen Z (currently 6-24 years old) opened a stock market account in the last 12 months.</p><p><blockquote>我们还看到前所未有的新市场参与者流入。在全球封锁期间，很少或没有市场经验的人以前所未有的速度开设了在线经纪账户。据《华尔街日报》报道，2020年有超过1000万美国人开设了交易账户。据美国消费者新闻与商业频道报道，10%的美国人在过去12个月内首次购买股票，惊人的22%的Z世代（目前6-24岁）在过去12个月内开设了股市账户。</blockquote></p><p>And stocks are not the only assets that are skyrocketing. Cryptocurrencies, which since 2017 had temporarily lost their luster, are rallying at breakneck pace since the outbreak of the pandemic (see exhibit 7).</p><p><blockquote>股票并不是唯一暴涨的资产。自2017年以来暂时失去光彩的加密货币，自疫情爆发以来正在以极快的速度反弹（见图表7）。</blockquote></p><p><img src=\"https://static.tigerbbs.com/46a4f01c4a7404c0a7b196d39dac0a78\" tg-width=\"500\" tg-height=\"424\" referrerpolicy=\"no-referrer\">Judged on only those metrics, stock markets are clearly in a bubble. But is this time maybe really different as the bulls argue? In our view, there are only two ways that current stock prices could indeed be justified;</p><p><blockquote>仅从这些指标来看，股市显然处于泡沫之中。但这一次真的像多头所说的那样不同吗？在我们看来，只有两种方式可以证明当前的股价是合理的：</blockquote></p><p></p><p><b>1. The great Gatsby:</b>The pandemic, as negative as it was for economic activity near term, will be followed by a period of unprecedented economic expansion. Hence, GDP will rapidly rise and close the gap to equity prices. <b>2. The great inflation:</b>Stocks simply price in future inflation that eventually will come on the back of decades of ultra-low rates and central bank balance sheet expansionWe will take a close look at the validity of those scenarios below. As we will show, these scenarios would require that we enter a multi-year period of extreme economic growth or inflation or a mix of both.&nbsp; However, we will show that gold should outperform stocks in either scenario. And if neither scenario comes true, then stock markets are due for a substantial correction. In that scenario, we would expect central banks to eventually intervene, which should ultimately also benefit gold. Hence, the fact that stocks have vastly outperformed gold over the past months is somewhat of a conundrum. But we are confident that this will reverse going forward.</p><p><blockquote><b>1.了不起的盖茨比：</b>尽管疫情在短期内对经济活动不利，但接下来将是一段前所未有的经济扩张时期。因此，GDP将迅速上升，并缩小与股票价格的差距。<b>2.大通货膨胀：</b>股票只是对未来的通胀进行定价，而未来的通胀最终将在数十年的超低利率和央行资产负债表扩张的背景下出现。我们将在下面仔细研究这些情景的有效性。正如我们将展示的，这些情景将要求我们进入一个多年的极端经济增长或通货膨胀或两者兼而有之的时期。然而，我们将表明，在这两种情况下，黄金的表现都应该优于股票。如果这两种情况都没有实现，那么股市将出现大幅调整。在这种情况下，我们预计央行最终会进行干预，这最终也应该有利于黄金。因此，过去几个月股票的表现远远优于黄金的事实在某种程度上是一个难题。但我们相信，这种情况将在未来逆转。</blockquote></p><p><b>Scenario one: The great Gatsby</b></p><p><blockquote><b>场景一：了不起的盖茨比</b></blockquote></p><p>Proponents of the great Gatsby scenario argue that, once the COVID19 pandemic is behind us as enough people are vaccinated and normality returns, economic activity will explode. The argumentation goes that there is a lot of pent-up demand as people were forced to save during the lockdowns and are eager to consume. This demand will be further fueled by stimulus checks (potentially in perpetuity, UBI). At the same time, governments around the world are rolling out huge green infrastructure programs, partially to combat climate change and partially to jump-start the economy.</p><p><blockquote>《了不起的盖茨比》的支持者认为，一旦COVID19疫情成为过去，有足够多的人接种疫苗，恢复正常，经济活动将会爆发。这种观点认为，由于人们在封锁期间被迫储蓄并渴望消费，因此存在大量被压抑的需求。刺激检查（可能是永久性的，UBI）将进一步推动这种需求。与此同时，世界各国政府正在推出庞大的绿色基础设施项目，部分是为了应对气候变化，部分是为了提振经济。</blockquote></p><p>While some of these deliberations have merit, there are a few important caveats. In our view, it is extremely unlikely for the economy to simply pick up where we left even if the current measures intended to contain the pandemic are completely removed. Many small businesses have closed forever or are about to close in the near term. The surviving businesses are aggressively cutting costs by a) laying off staff and b) trimming production. The former will impact on consumer demand going forward, the latter will impact on the businesses that are further up in the production chain. While there may be pent-up consumer demand from those who still have a job and saved a lot of money during lockdowns, there are also likely to be a lot of pent-up bankruptcies as many businesses have simply survived so far due to government intervention. Eventually many of those businesses will close. This is especially true in many European economies where governments de facto paid companies not to fire people.</p><p><blockquote>虽然其中一些审议有其优点，但也有一些重要的警告。我们认为，即使目前旨在遏制疫情的措施完全取消，经济也极不可能简单地从我们离开的地方恢复过来。许多小企业已经永远关闭或即将在短期内关闭。幸存的企业正在通过a)裁员和b)削减产量来积极削减成本。前者将影响未来的消费者需求，后者将影响生产链更上游的企业。虽然那些仍然有工作并在封锁期间存了很多钱的人可能会有被压抑的消费者需求，但也可能会有很多被压抑的破产，因为许多企业迄今为止只是由于政府干预而幸存下来。最终，许多这样的企业将会关闭。在许多欧洲经济体尤其如此，在这些经济体，政府实际上付钱给公司不要解雇员工。</blockquote></p><p>The problem is compounded by the fact that the economy was already stuttering long before Coronavirus became a household name. The Fed had to aggressively reverse its hiking cycle already by 3Q2019 as markets started to turn sour. We believe that we are close to or already in a recession by late 2019. Hence, a simple return to the pre-COVID economy would mean back to a “normal” recession. Thus, the drivers for this apparent future multi-year super growth cycle have to be strong enough to offset these bearish factors as well.</p><p><blockquote>早在冠状病毒成为家喻户晓的名字之前，经济就已经陷入困境，这一事实使问题变得更加复杂。随着市场开始恶化，美联储不得不在2019年第三季度之前大幅扭转加息周期。我们认为，到2019年底，我们将接近或已经陷入衰退。因此，简单地回到COVID之前的经济将意味着回到“正常”衰退。因此，这个明显的未来多年超级增长周期的驱动力必须足够强大，以抵消这些看跌因素。</blockquote></p><p>Then there is the magnitude by how much the economy would have to expand to justify these kind of equity valuations. If you take a simple metric like market cap to GDP, then GDP would have to almost double from current levels to be in line with historical averages. That implies a nominal GDP of $40tn, or 86% above the levels before COVID (average 2019). Granted that market cap to GDP was already inflated to around 1.2 on average in the ten years prior to the pandemic due to ultra-low interest rates, a return to that average would still require nominal GDP to rise to $35tn or 63% from pre-COVID levels.</p><p><blockquote>然后是经济必须扩张多少才能证明这种股票估值的合理性。如果你用一个简单的指标来衡量GDP，那么GDP必须比当前水平翻一番才能与历史平均水平保持一致。这意味着名义GDP为40万亿美元，比COVID之前的水平（2019年平均水平）高出86%。尽管由于超低利率，在大流行之前的十年里，市值与GDP之比已经平均膨胀至1.2左右，但要恢复到这一平均水平，仍需要名义GDP升至35万亿美元，即较前水平的63%。</blockquote></p><p>Even with a staggering 5% annual GDP growth and 2% inflation, it would still take more than seven years to get there. Are stocks really pricing in the year 2028 with 0% discount rate? And if so, what would be the fundamental driver to push stocks even higher from here? &nbsp;And is there even historic precedent for these kind of growth numbers? In the post WWII period, there have been only two instances where economic expansion was that high for a prolonged period (see Exhibit 8).</p><p><blockquote>即使GDP年增长率达到惊人的5%，通货膨胀率达到2%，仍需要七年多的时间才能实现。2028年股票真的以0%贴现率定价吗？如果是这样，推动股市进一步走高的根本驱动力是什么？这种增长数字有历史先例吗？在二战后时期，只有两次经济扩张在很长一段时间内如此之高（见图表8）。</blockquote></p><p>After WWII ended, the US saw a few years of moderate growth as government spending plummeted, followed by very high growth rates at around 6.9% between 1949 and 1953. This was possible as the US was one of the very few countries where none of the infrastructure had been destroyed and the rest of the world had to be rebuilt. However mathematically, even a repetition of the 1949-53 growth period over the coming years would not be enough to justify current stock prices as it lasted for “only” four years before the US fell into another recession.</p><p><blockquote>二战结束后，随着政府支出暴跌，美国经历了几年的温和增长，随后在1949年至1953年间实现了约6.9%的高增长率。这是可能的，因为美国是极少数基础设施没有被摧毁、世界其他地区必须重建的国家之一。然而，从数学上讲，即使在未来几年重复1949-53年的增长期也不足以证明当前股价的合理性，因为在美国陷入另一场衰退之前，它“只”持续了四年。</blockquote></p><p></p><p><img src=\"https://static.tigerbbs.com/e0e3916e88c1ee473c5ea235b229f969\" tg-width=\"500\" tg-height=\"420\" referrerpolicy=\"no-referrer\">From 1958-1969, the US economy was able to grow close to 5% with a brief monetary recession in 1960. In our view, this 1960s growth period is the only one that reflects the magnitude and length needed to get US GDP back in line with current equity prices. However, the economic environment of the 1960s looked very different from where we are now. More specifically, the US exited WWII with record debt to GPD of over 100%. However, it then immediately cut spending (which resulted in the slower growth rates in the immediate years after WWII) and reduced debt. Inflation also picked up, which, to some extent, helped reducing debt even further[1]. By 1959, the US government had reduced its debt held by the public to 44%, and it dropped to 27% by the end of the 60s (see exhibit 9).</p><p><blockquote>从1958年到1969年，美国经济能够增长近5%，1960年经历了短暂的货币衰退。我们认为，20世纪60年代的增长期是唯一反映美国GDP与当前股价接轨所需的规模和长度的时期。然而，20世纪60年代的经济环境看起来与我们现在有很大不同。更具体地说，美国退出二战时对GPD的债务超过100%。然而，它随后立即削减支出（这导致了二战后几年的增长率放缓）并减少了债务。通货膨胀也有所上升，这在某种程度上有助于进一步减少债务[1]。到1959年，美国政府将公众持有的债务降至44%，到60年代末又降至27%（见图表9）。</blockquote></p><p><img src=\"https://static.tigerbbs.com/4ee79afe5f74fa39abc86b197930c486\" tg-width=\"500\" tg-height=\"422\" referrerpolicy=\"no-referrer\">Additionally, 10-year treasury rates average at around 5% during this entire growth period. This is a stark contrast to the 1.5% we are seeing now (which already seem to rattle markets). Furthermore, the FED has no room to the downside, as Fed funds rates are already at zero percent. Hence, the only monetary stimulus that is left is via continued and even more extreme QE. However, as we have shown many times before (see&nbsp;Gold Price Framework Vol. 2: The energy side of the equation,&nbsp;<i>28 May 2018</i>), QE has always a huge and direct effect on gold prices, and gold is currently not pricing any of that in. Instead, the equity and gold markets seem to be pricing in economic expansion that is driven by anything but more monetary stimulus.</p><p><blockquote>此外，在整个增长期内，10年期国债利率平均约为5%。这与我们现在看到的1.5%形成鲜明对比（这似乎已经扰乱了市场）。此外，美联储没有下行空间，因为联邦基金利率已经为零。因此，剩下的唯一货币刺激是通过持续甚至更极端的量化宽松。然而，正如我们之前多次展示的那样（参见黄金价格框架第2卷：等式的能量面，<i>2018年5月28日</i>），QE总是对黄金价格产生巨大而直接的影响，而黄金目前并没有对其中的任何一项进行定价。相反，股票和黄金市场似乎正在为经济扩张定价，而经济扩张是由更多的货币刺激推动的。</blockquote></p><p>Another theme of the great Gatsby scenario is that governments will unleash massive transformation towards a greener future. This will lead to huge infrastructure investments in energy, transportation and commodity space, create jobs and unlock economic growth. While we believe that this is likely to be true, what the market seems to ignore is that this can only be financed with more government debt. Central banks will ultimately have to buy that debt, which has the same effect as QE as it leads to a growing balance sheet. And as we have outlined before, higher QE leads to higher gold prices. So again, if markets are pricing in economic expansion on the back of a “green new deal”, they seem to wrongly assume that this can be done without an effect on gold price.</p><p><blockquote>《了不起的盖茨比》的另一个主题是，政府将向更绿色的未来发起大规模变革。这将导致能源、交通和商品领域的巨额基础设施投资，创造就业机会并释放经济增长。虽然我们认为这很可能是真的，但市场似乎忽视的是，这只能通过更多的政府债务来融资。央行最终将不得不购买这些债务，这与量化宽松的效果相同，因为它会导致资产负债表不断扩大。正如我们之前概述的，更高的量化宽松会导致金价上涨。因此，如果市场在“绿色新政”的支持下定价经济扩张，他们似乎错误地认为这可以在不影响金价的情况下实现。</blockquote></p><p>Lastly, there is the idea that the COVID relief checks will continue indefinitely, de facto introducing a sort of Universal Basic Income (UBI). This would have an effect on consumer spending and, thus, corporate revenues. However, currently the US is running the largest deficit in history. If UBI becomes a reality, this would also have to be entirely financed via debt. As mentioned before, markets are not pricing this in, otherwise we would see an effect on gold.</p><p><blockquote>最后，有一种观点认为，COVID救济支票将无限期地继续下去，事实上引入了一种普遍基本收入（UBI）。这将对消费者支出产生影响，从而影响企业收入。然而，目前美国正面临历史上最大的赤字。如果UBI成为现实，这也必须完全通过债务融资。如前所述，市场没有对此进行定价，否则我们将看到对黄金的影响。</blockquote></p><p><b>Thus, the equity-gold conundrum doesn’t disappear in the great Gatsby scenario. In fact, we think that if we see strong economic growth over the coming years, it will entirely be debt financed and as a consequence gold should outperform stocks, not the other way around.</b></p><p><blockquote><b>因此，在《了不起的盖茨比》的场景中，股票-黄金难题并没有消失。事实上，我们认为，如果我们在未来几年看到强劲的经济增长，它将完全由债务融资，因此黄金的表现应该优于股票，而不是相反。</b></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>The Equity-Gold Price Conundrum, Part 1: The Great Batsby<blockquote>股票-黄金价格难题，第1部分：伟大的蝙蝠侠</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThe Equity-Gold Price Conundrum, Part 1: The Great Batsby<blockquote>股票-黄金价格难题，第1部分：伟大的蝙蝠侠</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">zerohedge</strong><span class=\"h-time small\">2021-03-10 18:11</span>\n</p>\n</h4>\n</header>\n<article>\n<p>The relentless rally in equity markets has pushed valuations to extreme levels based on traditional metrics. In this report, we analyze the two common arguments made by equity bulls on why this time is different and current valuations are justified. We find that either gold or equities are currently mispriced, as, a) both arguments would imply that gold should outperform stocks and b) if neither of the scenarios play out, equities are due for a substantial correction.</p><p><blockquote>根据传统指标，股市的持续上涨已将估值推至极端水平。在本报告中，我们分析了股票多头提出的两个常见论点，即为什么这次不同以及当前估值是合理的。我们发现，黄金或股票目前的定价都是错误的，因为a)这两种论点都意味着黄金的表现应该优于股票，b)如果这两种情况都没有发生，股票将出现大幅调整。</blockquote></p><p><img src=\"https://static.tigerbbs.com/95f7609bf84bf26bd5d2443fa9a7de86\" tg-width=\"500\" tg-height=\"445\" referrerpolicy=\"no-referrer\">Amidst the global COVID-19 pandemic, equities had staggering rally over the past 12 months. The S&amp;P500 almost doubled in less than a year from a low of 2240 on March 23, 2020 to currently 3860 at the time of writing. In addition, some narrower indices have done even better. Particularly certain technology stocks have relentlessly risen amidst an environment of economic stress.</p><p><blockquote>在全球新冠肺炎疫情中，股市在过去12个月中出现了惊人的反弹。标准普尔500指数在不到一年的时间里几乎翻了一番，从2020年3月23日的低点2240点升至撰写本文时目前的3860点。此外，一些较窄的指数表现甚至更好。尤其是某些科技股在经济压力的环境下持续上涨。</blockquote></p><p>This has led to a sharp increase in the equities-to-gold price ratio (see Exhibit 1) even as economic growth has collapsed while the Fed increased its balance sheet at an unprecedented level.</p><p><blockquote>这导致股票与黄金的价格比率急剧上升（见图表1），尽管经济增长已经崩溃，而美联储以前所未有的水平增加了资产负债表。</blockquote></p><p><img src=\"https://static.tigerbbs.com/a828b10b92375dfb19347e6c59314c83\" tg-width=\"500\" tg-height=\"405\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p>This increase in the equities-to-gold-ratio is not caused by gold performing poorly as prices for the yellow metal are up12% since the end of 2019. It’s simply a consequence of equities’ doing really well. But equity valuations according to traditional metrics have now approached extreme levels. For example, the total market cap to GDP (Buffet indicator) is currently at 193% (see exhibit 2), the highest on record, 50% above the peak during the dot.com bubble.</p><p><blockquote>股票与黄金比率的上升并不是由黄金表现不佳造成的，因为自2019年底以来，黄金价格上涨了12%。这只是股市表现良好的结果。但根据传统指标，股票估值现已接近极端水平。例如，总市值占GDP（巴菲特指标）目前为193%（见图表2），为有记录以来的最高水平，比互联网泡沫期间的峰值高出50%。</blockquote></p><p><img src=\"https://static.tigerbbs.com/e64899d2c53b18cc97b2dce33717c9af\" tg-width=\"500\" tg-height=\"428\" referrerpolicy=\"no-referrer\">Moreover, global equities to GDP are also extremely high, currently at &gt;120% (see exhibit 3).</p><p><blockquote>此外，全球股票占GDP的比例也极高，目前超过120%（见图表3）。</blockquote></p><p><img src=\"https://static.tigerbbs.com/ef426becc1777204ae2f18e3c290e2e6\" tg-width=\"500\" tg-height=\"436\" referrerpolicy=\"no-referrer\">The Cyclically Adjusted Price Earnings Ratio, or CAPE, a measure developed by Robert Schiller, is also flashing red with the second highest reading in history going back to the late 1900s (see exhibit 4).</p><p><blockquote>周期性调整市盈率（CAPE）是罗伯特·席勒（Robert Schiller）开发的一种衡量标准，也呈红色，其读数是自1900年代末以来历史上第二高的读数（见图表4）。</blockquote></p><p><img src=\"https://static.tigerbbs.com/8cc92db52653acc17b59de9311c17bf0\" tg-width=\"500\" tg-height=\"442\" referrerpolicy=\"no-referrer\">Price to sales ratios also hit a record high (see Exhibit 5).</p><p><blockquote>市销率也创下历史新高（见图表5）。</blockquote></p><p><img src=\"https://static.tigerbbs.com/a119fa360112d18ced5d8efff557ebea\" tg-width=\"500\" tg-height=\"436\" referrerpolicy=\"no-referrer\">There are other indicators that suggest that equity prices have detached from underlying fundamentals. The put / call ratio on the CBOE has now reached the levels of the dot.com bubble (see Exhibit 6).</p><p><blockquote>还有其他指标表明股价已经脱离了基本面。芝加哥期权交易所的看跌/看涨期权比率现在已经达到了互联网泡沫的水平（见图表6）。</blockquote></p><p><img src=\"https://static.tigerbbs.com/462aa5d4dee82e50792b2a4f6bbd70f8\" tg-width=\"500\" tg-height=\"389\" referrerpolicy=\"no-referrer\">We also saw an unprecedented inflow of new market participants. People with very little or no market exp4erience opened online brokerage accounts at an unprecedented speed during the global lockdowns. More than 10 million Americans opened a trading account in 2020 according to the Wall Street Journal.&nbsp; According to CNBC, ten percent of Americans bought a stock for the first time in the past 12 months, and a staggering twenty-two percent of Gen Z (currently 6-24 years old) opened a stock market account in the last 12 months.</p><p><blockquote>我们还看到前所未有的新市场参与者流入。在全球封锁期间，很少或没有市场经验的人以前所未有的速度开设了在线经纪账户。据《华尔街日报》报道，2020年有超过1000万美国人开设了交易账户。据美国消费者新闻与商业频道报道，10%的美国人在过去12个月内首次购买股票，惊人的22%的Z世代（目前6-24岁）在过去12个月内开设了股市账户。</blockquote></p><p>And stocks are not the only assets that are skyrocketing. Cryptocurrencies, which since 2017 had temporarily lost their luster, are rallying at breakneck pace since the outbreak of the pandemic (see exhibit 7).</p><p><blockquote>股票并不是唯一暴涨的资产。自2017年以来暂时失去光彩的加密货币，自疫情爆发以来正在以极快的速度反弹（见图表7）。</blockquote></p><p><img src=\"https://static.tigerbbs.com/46a4f01c4a7404c0a7b196d39dac0a78\" tg-width=\"500\" tg-height=\"424\" referrerpolicy=\"no-referrer\">Judged on only those metrics, stock markets are clearly in a bubble. But is this time maybe really different as the bulls argue? In our view, there are only two ways that current stock prices could indeed be justified;</p><p><blockquote>仅从这些指标来看，股市显然处于泡沫之中。但这一次真的像多头所说的那样不同吗？在我们看来，只有两种方式可以证明当前的股价是合理的：</blockquote></p><p></p><p><b>1. The great Gatsby:</b>The pandemic, as negative as it was for economic activity near term, will be followed by a period of unprecedented economic expansion. Hence, GDP will rapidly rise and close the gap to equity prices. <b>2. The great inflation:</b>Stocks simply price in future inflation that eventually will come on the back of decades of ultra-low rates and central bank balance sheet expansionWe will take a close look at the validity of those scenarios below. As we will show, these scenarios would require that we enter a multi-year period of extreme economic growth or inflation or a mix of both.&nbsp; However, we will show that gold should outperform stocks in either scenario. And if neither scenario comes true, then stock markets are due for a substantial correction. In that scenario, we would expect central banks to eventually intervene, which should ultimately also benefit gold. Hence, the fact that stocks have vastly outperformed gold over the past months is somewhat of a conundrum. But we are confident that this will reverse going forward.</p><p><blockquote><b>1.了不起的盖茨比：</b>尽管疫情在短期内对经济活动不利，但接下来将是一段前所未有的经济扩张时期。因此，GDP将迅速上升，并缩小与股票价格的差距。<b>2.大通货膨胀：</b>股票只是对未来的通胀进行定价，而未来的通胀最终将在数十年的超低利率和央行资产负债表扩张的背景下出现。我们将在下面仔细研究这些情景的有效性。正如我们将展示的，这些情景将要求我们进入一个多年的极端经济增长或通货膨胀或两者兼而有之的时期。然而，我们将表明，在这两种情况下，黄金的表现都应该优于股票。如果这两种情况都没有实现，那么股市将出现大幅调整。在这种情况下，我们预计央行最终会进行干预，这最终也应该有利于黄金。因此，过去几个月股票的表现远远优于黄金的事实在某种程度上是一个难题。但我们相信，这种情况将在未来逆转。</blockquote></p><p><b>Scenario one: The great Gatsby</b></p><p><blockquote><b>场景一：了不起的盖茨比</b></blockquote></p><p>Proponents of the great Gatsby scenario argue that, once the COVID19 pandemic is behind us as enough people are vaccinated and normality returns, economic activity will explode. The argumentation goes that there is a lot of pent-up demand as people were forced to save during the lockdowns and are eager to consume. This demand will be further fueled by stimulus checks (potentially in perpetuity, UBI). At the same time, governments around the world are rolling out huge green infrastructure programs, partially to combat climate change and partially to jump-start the economy.</p><p><blockquote>《了不起的盖茨比》的支持者认为，一旦COVID19疫情成为过去，有足够多的人接种疫苗，恢复正常，经济活动将会爆发。这种观点认为，由于人们在封锁期间被迫储蓄并渴望消费，因此存在大量被压抑的需求。刺激检查（可能是永久性的，UBI）将进一步推动这种需求。与此同时，世界各国政府正在推出庞大的绿色基础设施项目，部分是为了应对气候变化，部分是为了提振经济。</blockquote></p><p>While some of these deliberations have merit, there are a few important caveats. In our view, it is extremely unlikely for the economy to simply pick up where we left even if the current measures intended to contain the pandemic are completely removed. Many small businesses have closed forever or are about to close in the near term. The surviving businesses are aggressively cutting costs by a) laying off staff and b) trimming production. The former will impact on consumer demand going forward, the latter will impact on the businesses that are further up in the production chain. While there may be pent-up consumer demand from those who still have a job and saved a lot of money during lockdowns, there are also likely to be a lot of pent-up bankruptcies as many businesses have simply survived so far due to government intervention. Eventually many of those businesses will close. This is especially true in many European economies where governments de facto paid companies not to fire people.</p><p><blockquote>虽然其中一些审议有其优点，但也有一些重要的警告。我们认为，即使目前旨在遏制疫情的措施完全取消，经济也极不可能简单地从我们离开的地方恢复过来。许多小企业已经永远关闭或即将在短期内关闭。幸存的企业正在通过a)裁员和b)削减产量来积极削减成本。前者将影响未来的消费者需求，后者将影响生产链更上游的企业。虽然那些仍然有工作并在封锁期间存了很多钱的人可能会有被压抑的消费者需求，但也可能会有很多被压抑的破产，因为许多企业迄今为止只是由于政府干预而幸存下来。最终，许多这样的企业将会关闭。在许多欧洲经济体尤其如此，在这些经济体，政府实际上付钱给公司不要解雇员工。</blockquote></p><p>The problem is compounded by the fact that the economy was already stuttering long before Coronavirus became a household name. The Fed had to aggressively reverse its hiking cycle already by 3Q2019 as markets started to turn sour. We believe that we are close to or already in a recession by late 2019. Hence, a simple return to the pre-COVID economy would mean back to a “normal” recession. Thus, the drivers for this apparent future multi-year super growth cycle have to be strong enough to offset these bearish factors as well.</p><p><blockquote>早在冠状病毒成为家喻户晓的名字之前，经济就已经陷入困境，这一事实使问题变得更加复杂。随着市场开始恶化，美联储不得不在2019年第三季度之前大幅扭转加息周期。我们认为，到2019年底，我们将接近或已经陷入衰退。因此，简单地回到COVID之前的经济将意味着回到“正常”衰退。因此，这个明显的未来多年超级增长周期的驱动力必须足够强大，以抵消这些看跌因素。</blockquote></p><p>Then there is the magnitude by how much the economy would have to expand to justify these kind of equity valuations. If you take a simple metric like market cap to GDP, then GDP would have to almost double from current levels to be in line with historical averages. That implies a nominal GDP of $40tn, or 86% above the levels before COVID (average 2019). Granted that market cap to GDP was already inflated to around 1.2 on average in the ten years prior to the pandemic due to ultra-low interest rates, a return to that average would still require nominal GDP to rise to $35tn or 63% from pre-COVID levels.</p><p><blockquote>然后是经济必须扩张多少才能证明这种股票估值的合理性。如果你用一个简单的指标来衡量GDP，那么GDP必须比当前水平翻一番才能与历史平均水平保持一致。这意味着名义GDP为40万亿美元，比COVID之前的水平（2019年平均水平）高出86%。尽管由于超低利率，在大流行之前的十年里，市值与GDP之比已经平均膨胀至1.2左右，但要恢复到这一平均水平，仍需要名义GDP升至35万亿美元，即较前水平的63%。</blockquote></p><p>Even with a staggering 5% annual GDP growth and 2% inflation, it would still take more than seven years to get there. Are stocks really pricing in the year 2028 with 0% discount rate? And if so, what would be the fundamental driver to push stocks even higher from here? &nbsp;And is there even historic precedent for these kind of growth numbers? In the post WWII period, there have been only two instances where economic expansion was that high for a prolonged period (see Exhibit 8).</p><p><blockquote>即使GDP年增长率达到惊人的5%，通货膨胀率达到2%，仍需要七年多的时间才能实现。2028年股票真的以0%贴现率定价吗？如果是这样，推动股市进一步走高的根本驱动力是什么？这种增长数字有历史先例吗？在二战后时期，只有两次经济扩张在很长一段时间内如此之高（见图表8）。</blockquote></p><p>After WWII ended, the US saw a few years of moderate growth as government spending plummeted, followed by very high growth rates at around 6.9% between 1949 and 1953. This was possible as the US was one of the very few countries where none of the infrastructure had been destroyed and the rest of the world had to be rebuilt. However mathematically, even a repetition of the 1949-53 growth period over the coming years would not be enough to justify current stock prices as it lasted for “only” four years before the US fell into another recession.</p><p><blockquote>二战结束后，随着政府支出暴跌，美国经历了几年的温和增长，随后在1949年至1953年间实现了约6.9%的高增长率。这是可能的，因为美国是极少数基础设施没有被摧毁、世界其他地区必须重建的国家之一。然而，从数学上讲，即使在未来几年重复1949-53年的增长期也不足以证明当前股价的合理性，因为在美国陷入另一场衰退之前，它“只”持续了四年。</blockquote></p><p></p><p><img src=\"https://static.tigerbbs.com/e0e3916e88c1ee473c5ea235b229f969\" tg-width=\"500\" tg-height=\"420\" referrerpolicy=\"no-referrer\">From 1958-1969, the US economy was able to grow close to 5% with a brief monetary recession in 1960. In our view, this 1960s growth period is the only one that reflects the magnitude and length needed to get US GDP back in line with current equity prices. However, the economic environment of the 1960s looked very different from where we are now. More specifically, the US exited WWII with record debt to GPD of over 100%. However, it then immediately cut spending (which resulted in the slower growth rates in the immediate years after WWII) and reduced debt. Inflation also picked up, which, to some extent, helped reducing debt even further[1]. By 1959, the US government had reduced its debt held by the public to 44%, and it dropped to 27% by the end of the 60s (see exhibit 9).</p><p><blockquote>从1958年到1969年，美国经济能够增长近5%，1960年经历了短暂的货币衰退。我们认为，20世纪60年代的增长期是唯一反映美国GDP与当前股价接轨所需的规模和长度的时期。然而，20世纪60年代的经济环境看起来与我们现在有很大不同。更具体地说，美国退出二战时对GPD的债务超过100%。然而，它随后立即削减支出（这导致了二战后几年的增长率放缓）并减少了债务。通货膨胀也有所上升，这在某种程度上有助于进一步减少债务[1]。到1959年，美国政府将公众持有的债务降至44%，到60年代末又降至27%（见图表9）。</blockquote></p><p><img src=\"https://static.tigerbbs.com/4ee79afe5f74fa39abc86b197930c486\" tg-width=\"500\" tg-height=\"422\" referrerpolicy=\"no-referrer\">Additionally, 10-year treasury rates average at around 5% during this entire growth period. This is a stark contrast to the 1.5% we are seeing now (which already seem to rattle markets). Furthermore, the FED has no room to the downside, as Fed funds rates are already at zero percent. Hence, the only monetary stimulus that is left is via continued and even more extreme QE. However, as we have shown many times before (see&nbsp;Gold Price Framework Vol. 2: The energy side of the equation,&nbsp;<i>28 May 2018</i>), QE has always a huge and direct effect on gold prices, and gold is currently not pricing any of that in. Instead, the equity and gold markets seem to be pricing in economic expansion that is driven by anything but more monetary stimulus.</p><p><blockquote>此外，在整个增长期内，10年期国债利率平均约为5%。这与我们现在看到的1.5%形成鲜明对比（这似乎已经扰乱了市场）。此外，美联储没有下行空间，因为联邦基金利率已经为零。因此，剩下的唯一货币刺激是通过持续甚至更极端的量化宽松。然而，正如我们之前多次展示的那样（参见黄金价格框架第2卷：等式的能量面，<i>2018年5月28日</i>），QE总是对黄金价格产生巨大而直接的影响，而黄金目前并没有对其中的任何一项进行定价。相反，股票和黄金市场似乎正在为经济扩张定价，而经济扩张是由更多的货币刺激推动的。</blockquote></p><p>Another theme of the great Gatsby scenario is that governments will unleash massive transformation towards a greener future. This will lead to huge infrastructure investments in energy, transportation and commodity space, create jobs and unlock economic growth. While we believe that this is likely to be true, what the market seems to ignore is that this can only be financed with more government debt. Central banks will ultimately have to buy that debt, which has the same effect as QE as it leads to a growing balance sheet. And as we have outlined before, higher QE leads to higher gold prices. So again, if markets are pricing in economic expansion on the back of a “green new deal”, they seem to wrongly assume that this can be done without an effect on gold price.</p><p><blockquote>《了不起的盖茨比》的另一个主题是，政府将向更绿色的未来发起大规模变革。这将导致能源、交通和商品领域的巨额基础设施投资，创造就业机会并释放经济增长。虽然我们认为这很可能是真的，但市场似乎忽视的是，这只能通过更多的政府债务来融资。央行最终将不得不购买这些债务，这与量化宽松的效果相同，因为它会导致资产负债表不断扩大。正如我们之前概述的，更高的量化宽松会导致金价上涨。因此，如果市场在“绿色新政”的支持下定价经济扩张，他们似乎错误地认为这可以在不影响金价的情况下实现。</blockquote></p><p>Lastly, there is the idea that the COVID relief checks will continue indefinitely, de facto introducing a sort of Universal Basic Income (UBI). This would have an effect on consumer spending and, thus, corporate revenues. However, currently the US is running the largest deficit in history. If UBI becomes a reality, this would also have to be entirely financed via debt. As mentioned before, markets are not pricing this in, otherwise we would see an effect on gold.</p><p><blockquote>最后，有一种观点认为，COVID救济支票将无限期地继续下去，事实上引入了一种普遍基本收入（UBI）。这将对消费者支出产生影响，从而影响企业收入。然而，目前美国正面临历史上最大的赤字。如果UBI成为现实，这也必须完全通过债务融资。如前所述，市场没有对此进行定价，否则我们将看到对黄金的影响。</blockquote></p><p><b>Thus, the equity-gold conundrum doesn’t disappear in the great Gatsby scenario. In fact, we think that if we see strong economic growth over the coming years, it will entirely be debt financed and as a consequence gold should outperform stocks, not the other way around.</b></p><p><blockquote><b>因此，在《了不起的盖茨比》的场景中，股票-黄金难题并没有消失。事实上，我们认为，如果我们在未来几年看到强劲的经济增长，它将完全由债务融资，因此黄金的表现应该优于股票，而不是相反。</b></blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.zerohedge.com/markets/equity-gold-price-conundrum-part-1-great-batsby?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+zerohege%2Ffeed+%28zero+hedge+-+on+a+long+enough+timeline%2C+the+survival+rate+for+everyone+drops+to+zero%29\">zerohedge</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.zerohedge.com/markets/equity-gold-price-conundrum-part-1-great-batsby?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+zerohege%2Ffeed+%28zero+hedge+-+on+a+long+enough+timeline%2C+the+survival+rate+for+everyone+drops+to+zero%29","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1162030727","content_text":"The relentless rally in equity markets has pushed valuations to extreme levels based on traditional metrics. In this report, we analyze the two common arguments made by equity bulls on why this time is different and current valuations are justified. We find that either gold or equities are currently mispriced, as, a) both arguments would imply that gold should outperform stocks and b) if neither of the scenarios play out, equities are due for a substantial correction.Amidst the global COVID-19 pandemic, equities had staggering rally over the past 12 months. The S&P500 almost doubled in less than a year from a low of 2240 on March 23, 2020 to currently 3860 at the time of writing. In addition, some narrower indices have done even better. Particularly certain technology stocks have relentlessly risen amidst an environment of economic stress.This has led to a sharp increase in the equities-to-gold price ratio (see Exhibit 1) even as economic growth has collapsed while the Fed increased its balance sheet at an unprecedented level.This increase in the equities-to-gold-ratio is not caused by gold performing poorly as prices for the yellow metal are up12% since the end of 2019. It’s simply a consequence of equities’ doing really well. But equity valuations according to traditional metrics have now approached extreme levels. For example, the total market cap to GDP (Buffet indicator) is currently at 193% (see exhibit 2), the highest on record, 50% above the peak during the dot.com bubble.Moreover, global equities to GDP are also extremely high, currently at >120% (see exhibit 3).The Cyclically Adjusted Price Earnings Ratio, or CAPE, a measure developed by Robert Schiller, is also flashing red with the second highest reading in history going back to the late 1900s (see exhibit 4).Price to sales ratios also hit a record high (see Exhibit 5).There are other indicators that suggest that equity prices have detached from underlying fundamentals. The put / call ratio on the CBOE has now reached the levels of the dot.com bubble (see Exhibit 6).We also saw an unprecedented inflow of new market participants. People with very little or no market exp4erience opened online brokerage accounts at an unprecedented speed during the global lockdowns. More than 10 million Americans opened a trading account in 2020 according to the Wall Street Journal.  According to CNBC, ten percent of Americans bought a stock for the first time in the past 12 months, and a staggering twenty-two percent of Gen Z (currently 6-24 years old) opened a stock market account in the last 12 months.And stocks are not the only assets that are skyrocketing. Cryptocurrencies, which since 2017 had temporarily lost their luster, are rallying at breakneck pace since the outbreak of the pandemic (see exhibit 7).Judged on only those metrics, stock markets are clearly in a bubble. But is this time maybe really different as the bulls argue? In our view, there are only two ways that current stock prices could indeed be justified;1. The great Gatsby:The pandemic, as negative as it was for economic activity near term, will be followed by a period of unprecedented economic expansion. Hence, GDP will rapidly rise and close the gap to equity prices. 2. The great inflation:Stocks simply price in future inflation that eventually will come on the back of decades of ultra-low rates and central bank balance sheet expansionWe will take a close look at the validity of those scenarios below. As we will show, these scenarios would require that we enter a multi-year period of extreme economic growth or inflation or a mix of both.  However, we will show that gold should outperform stocks in either scenario. And if neither scenario comes true, then stock markets are due for a substantial correction. In that scenario, we would expect central banks to eventually intervene, which should ultimately also benefit gold. Hence, the fact that stocks have vastly outperformed gold over the past months is somewhat of a conundrum. But we are confident that this will reverse going forward.Scenario one: The great GatsbyProponents of the great Gatsby scenario argue that, once the COVID19 pandemic is behind us as enough people are vaccinated and normality returns, economic activity will explode. The argumentation goes that there is a lot of pent-up demand as people were forced to save during the lockdowns and are eager to consume. This demand will be further fueled by stimulus checks (potentially in perpetuity, UBI). At the same time, governments around the world are rolling out huge green infrastructure programs, partially to combat climate change and partially to jump-start the economy.While some of these deliberations have merit, there are a few important caveats. In our view, it is extremely unlikely for the economy to simply pick up where we left even if the current measures intended to contain the pandemic are completely removed. Many small businesses have closed forever or are about to close in the near term. The surviving businesses are aggressively cutting costs by a) laying off staff and b) trimming production. The former will impact on consumer demand going forward, the latter will impact on the businesses that are further up in the production chain. While there may be pent-up consumer demand from those who still have a job and saved a lot of money during lockdowns, there are also likely to be a lot of pent-up bankruptcies as many businesses have simply survived so far due to government intervention. Eventually many of those businesses will close. This is especially true in many European economies where governments de facto paid companies not to fire people.The problem is compounded by the fact that the economy was already stuttering long before Coronavirus became a household name. The Fed had to aggressively reverse its hiking cycle already by 3Q2019 as markets started to turn sour. We believe that we are close to or already in a recession by late 2019. Hence, a simple return to the pre-COVID economy would mean back to a “normal” recession. Thus, the drivers for this apparent future multi-year super growth cycle have to be strong enough to offset these bearish factors as well.Then there is the magnitude by how much the economy would have to expand to justify these kind of equity valuations. If you take a simple metric like market cap to GDP, then GDP would have to almost double from current levels to be in line with historical averages. That implies a nominal GDP of $40tn, or 86% above the levels before COVID (average 2019). Granted that market cap to GDP was already inflated to around 1.2 on average in the ten years prior to the pandemic due to ultra-low interest rates, a return to that average would still require nominal GDP to rise to $35tn or 63% from pre-COVID levels.Even with a staggering 5% annual GDP growth and 2% inflation, it would still take more than seven years to get there. Are stocks really pricing in the year 2028 with 0% discount rate? And if so, what would be the fundamental driver to push stocks even higher from here?  And is there even historic precedent for these kind of growth numbers? In the post WWII period, there have been only two instances where economic expansion was that high for a prolonged period (see Exhibit 8).After WWII ended, the US saw a few years of moderate growth as government spending plummeted, followed by very high growth rates at around 6.9% between 1949 and 1953. This was possible as the US was one of the very few countries where none of the infrastructure had been destroyed and the rest of the world had to be rebuilt. However mathematically, even a repetition of the 1949-53 growth period over the coming years would not be enough to justify current stock prices as it lasted for “only” four years before the US fell into another recession.From 1958-1969, the US economy was able to grow close to 5% with a brief monetary recession in 1960. In our view, this 1960s growth period is the only one that reflects the magnitude and length needed to get US GDP back in line with current equity prices. However, the economic environment of the 1960s looked very different from where we are now. More specifically, the US exited WWII with record debt to GPD of over 100%. However, it then immediately cut spending (which resulted in the slower growth rates in the immediate years after WWII) and reduced debt. Inflation also picked up, which, to some extent, helped reducing debt even further[1]. By 1959, the US government had reduced its debt held by the public to 44%, and it dropped to 27% by the end of the 60s (see exhibit 9).Additionally, 10-year treasury rates average at around 5% during this entire growth period. This is a stark contrast to the 1.5% we are seeing now (which already seem to rattle markets). Furthermore, the FED has no room to the downside, as Fed funds rates are already at zero percent. Hence, the only monetary stimulus that is left is via continued and even more extreme QE. However, as we have shown many times before (see Gold Price Framework Vol. 2: The energy side of the equation, 28 May 2018), QE has always a huge and direct effect on gold prices, and gold is currently not pricing any of that in. Instead, the equity and gold markets seem to be pricing in economic expansion that is driven by anything but more monetary stimulus.Another theme of the great Gatsby scenario is that governments will unleash massive transformation towards a greener future. This will lead to huge infrastructure investments in energy, transportation and commodity space, create jobs and unlock economic growth. While we believe that this is likely to be true, what the market seems to ignore is that this can only be financed with more government debt. Central banks will ultimately have to buy that debt, which has the same effect as QE as it leads to a growing balance sheet. And as we have outlined before, higher QE leads to higher gold prices. So again, if markets are pricing in economic expansion on the back of a “green new deal”, they seem to wrongly assume that this can be done without an effect on gold price.Lastly, there is the idea that the COVID relief checks will continue indefinitely, de facto introducing a sort of Universal Basic Income (UBI). This would have an effect on consumer spending and, thus, corporate revenues. However, currently the US is running the largest deficit in history. If UBI becomes a reality, this would also have to be entirely financed via debt. As mentioned before, markets are not pricing this in, otherwise we would see an effect on gold.Thus, the equity-gold conundrum doesn’t disappear in the great Gatsby scenario. In fact, we think that if we see strong economic growth over the coming years, it will entirely be debt financed and as a consequence gold should outperform stocks, not the other way around.","news_type":1,"symbols_score_info":{}},"isVote":1,"tweetType":1,"viewCount":502,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":107764648,"gmtCreate":1620540922784,"gmtModify":1634198132790,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3575416215572570","idStr":"3575416215572570"},"themes":[],"htmlText":"Go for it","listText":"Go for it","text":"Go for it","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/107764648","repostId":"1106882084","repostType":4,"isVote":1,"tweetType":1,"viewCount":506,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":374257611,"gmtCreate":1619450791633,"gmtModify":1634273344074,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3575416215572570","idStr":"3575416215572570"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>cry tiger","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>cry tiger","text":"$Tiger Brokers(TIGR)$cry tiger","images":[{"img":"https://static.tigerbbs.com/673586a63f14b099924e7a415a100291","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/374257611","isVote":1,"tweetType":1,"viewCount":599,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3573719572697574","authorId":"3573719572697574","name":"张大发同学","avatar":"https://static.tigerbbs.com/3fd7bf41ad5567dd93aae0ed6e28e6fe","crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3573719572697574","idStr":"3573719572697574"},"content":"我从31一直加到14回血的","text":"我从31一直加到14回血的","html":"我从31一直加到14回血的"}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":894990649,"gmtCreate":1628780633881,"gmtModify":1631892264507,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3575416215572570","idStr":"3575416215572570"},"themes":[],"htmlText":"All the way","listText":"All the way","text":"All the way","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/894990649","repostId":"2158325931","repostType":4,"repost":{"id":"2158325931","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1628776169,"share":"https://www.laohu8.com/m/news/2158325931?lang=zh_CN&edition=full","pubTime":"2021-08-12 21:49","market":"us","language":"en","title":"BioNTech, Moderna Gain on Report of FDA’s Likely Nod for Booster<blockquote>BioNTech和Moderna因FDA可能批准增强剂的报道而上涨</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=2158325931","media":"Tiger Newspress","summary":"BioNTech and Moderna stock rose in early trading on Thursday, on track to recover some of the previo","content":"<p>BioNTech&nbsp;and Moderna&nbsp;stock rose in&nbsp;early&nbsp;trading&nbsp;on Thursday, on track to recover some of the previous session’s losses, following a report in the Wall Street Journal that the FDA could authorize Covid-19 booster shots for immunocompromised people.</p><p><blockquote>BioNTech和Moderna股价周四早盘上涨，有望收复前一交易日的部分跌幅，此前《华尔街日报》报道称FDA可能授权为免疫功能低下的人注射Covid-19加强针。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/2860e1c0dcbf5f35624516c9d0ff29db\" tg-width=\"895\" tg-height=\"647\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> BioNTech and Moderna were up 3.96% and 2% after plunging 14% and 15.6% in the previous session, respectively. Pfizer (NYSE:PFE), which shed 4% on Wednesday, was up 1%.</p><p><blockquote>BioNTech和Moderna在前一交易日分别暴跌14%和15.6%后上涨3.96%和2%。辉瑞(NYSE：PFE)周三下跌4%，现上涨1%。</blockquote></p><p> The WSJ reported that the Food and Drug Administration is nearing a decision to authorize booster shots for people with weak immunity amid a surge in new COVID cases because of the rapid spread of the delta variant.</p><p><blockquote>《华尔街日报》报道称，由于德尔塔变异毒株的快速传播，新冠病例激增，美国食品和药物管理局即将决定授权为免疫力较弱的人进行加强注射。</blockquote></p><p> There is growing evidence that two shots of the vaccines are inadequate for people with low immunity. Vaccine makers plan to approach the FDA this month or next for approval to their booster shots.</p><p><blockquote>越来越多的证据表明，对于免疫力低下的人来说，两针疫苗是不够的。疫苗制造商计划在本月或下个月向FDA申请加强注射的批准。</blockquote></p><p> BioNTech, Moderna and Pfizer all closed lower Wednesday following news that Europe’s drug regulator is studying three new conditions reported by a small number of people after getting Covid-19 shots to assess if they may be possible side-effects.</p><p><blockquote>BioNTech、Moderna和辉瑞周三均收低，此前有消息称，欧洲药品监管机构正在研究少数人在接种Covid-19疫苗后报告的三种新病症，以评估它们是否可能是副作用。</blockquote></p><p> The conditions were reported in patients who took the mRNA vaccines made by either Moderna or BioNTech-Pfizer.</p><p><blockquote>据报道，服用Moderna或BioNTech-Pfizer生产的mRNA疫苗的患者出现了这种情况。</blockquote></p><p> Pfizer and BioNTech are collaborating on the research and marketing of their COVID-19 vaccine. Expenses and profit from the vaccine are split equally between Pfizer and BioNTech.</p><p><blockquote>辉瑞和BioNTech正在合作研究和营销他们的新冠肺炎疫苗。疫苗的费用和利润由辉瑞和BioNTech平分。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BioNTech, Moderna Gain on Report of FDA’s Likely Nod for Booster<blockquote>BioNTech和Moderna因FDA可能批准增强剂的报道而上涨</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBioNTech, Moderna Gain on Report of FDA’s Likely Nod for Booster<blockquote>BioNTech和Moderna因FDA可能批准增强剂的报道而上涨</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-08-12 21:49</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>BioNTech&nbsp;and Moderna&nbsp;stock rose in&nbsp;early&nbsp;trading&nbsp;on Thursday, on track to recover some of the previous session’s losses, following a report in the Wall Street Journal that the FDA could authorize Covid-19 booster shots for immunocompromised people.</p><p><blockquote>BioNTech和Moderna股价周四早盘上涨，有望收复前一交易日的部分跌幅，此前《华尔街日报》报道称FDA可能授权为免疫功能低下的人注射Covid-19加强针。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/2860e1c0dcbf5f35624516c9d0ff29db\" tg-width=\"895\" tg-height=\"647\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> BioNTech and Moderna were up 3.96% and 2% after plunging 14% and 15.6% in the previous session, respectively. Pfizer (NYSE:PFE), which shed 4% on Wednesday, was up 1%.</p><p><blockquote>BioNTech和Moderna在前一交易日分别暴跌14%和15.6%后上涨3.96%和2%。辉瑞(NYSE：PFE)周三下跌4%，现上涨1%。</blockquote></p><p> The WSJ reported that the Food and Drug Administration is nearing a decision to authorize booster shots for people with weak immunity amid a surge in new COVID cases because of the rapid spread of the delta variant.</p><p><blockquote>《华尔街日报》报道称，由于德尔塔变异毒株的快速传播，新冠病例激增，美国食品和药物管理局即将决定授权为免疫力较弱的人进行加强注射。</blockquote></p><p> There is growing evidence that two shots of the vaccines are inadequate for people with low immunity. Vaccine makers plan to approach the FDA this month or next for approval to their booster shots.</p><p><blockquote>越来越多的证据表明，对于免疫力低下的人来说，两针疫苗是不够的。疫苗制造商计划在本月或下个月向FDA申请加强注射的批准。</blockquote></p><p> BioNTech, Moderna and Pfizer all closed lower Wednesday following news that Europe’s drug regulator is studying three new conditions reported by a small number of people after getting Covid-19 shots to assess if they may be possible side-effects.</p><p><blockquote>BioNTech、Moderna和辉瑞周三均收低，此前有消息称，欧洲药品监管机构正在研究少数人在接种Covid-19疫苗后报告的三种新病症，以评估它们是否可能是副作用。</blockquote></p><p> The conditions were reported in patients who took the mRNA vaccines made by either Moderna or BioNTech-Pfizer.</p><p><blockquote>据报道，服用Moderna或BioNTech-Pfizer生产的mRNA疫苗的患者出现了这种情况。</blockquote></p><p> Pfizer and BioNTech are collaborating on the research and marketing of their COVID-19 vaccine. Expenses and profit from the vaccine are split equally between Pfizer and BioNTech.</p><p><blockquote>辉瑞和BioNTech正在合作研究和营销他们的新冠肺炎疫苗。疫苗的费用和利润由辉瑞和BioNTech平分。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","MRNA":"Moderna, Inc.","BNTX":"BioNTech SE"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2158325931","content_text":"BioNTech and Moderna stock rose in early trading on Thursday, on track to recover some of the previous session’s losses, following a report in the Wall Street Journal that the FDA could authorize Covid-19 booster shots for immunocompromised people.\n\nBioNTech and Moderna were up 3.96% and 2% after plunging 14% and 15.6% in the previous session, respectively. Pfizer (NYSE:PFE), which shed 4% on Wednesday, was up 1%.\nThe WSJ reported that the Food and Drug Administration is nearing a decision to authorize booster shots for people with weak immunity amid a surge in new COVID cases because of the rapid spread of the delta variant.\nThere is growing evidence that two shots of the vaccines are inadequate for people with low immunity. Vaccine makers plan to approach the FDA this month or next for approval to their booster shots.\nBioNTech, Moderna and Pfizer all closed lower Wednesday following news that Europe’s drug regulator is studying three new conditions reported by a small number of people after getting Covid-19 shots to assess if they may be possible side-effects.\nThe conditions were reported in patients who took the mRNA vaccines made by either Moderna or BioNTech-Pfizer.\nPfizer and BioNTech are collaborating on the research and marketing of their COVID-19 vaccine. Expenses and profit from the vaccine are split equally between Pfizer and BioNTech.","news_type":1,"symbols_score_info":{"PFE":0.9,"MRNA":0.9,"BNTX":0.9}},"isVote":1,"tweetType":1,"viewCount":1629,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":138407381,"gmtCreate":1621952095743,"gmtModify":1634185190253,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3575416215572570","idStr":"3575416215572570"},"themes":[],"htmlText":"Go up and down","listText":"Go up and down","text":"Go up and down","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/138407381","repostId":"1150619526","repostType":4,"repost":{"id":"1150619526","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1621951262,"share":"https://www.laohu8.com/m/news/1150619526?lang=zh_CN&edition=full","pubTime":"2021-05-25 22:01","market":"us","language":"en","title":"Moderna shares once gained more than 4%<blockquote>Moderna股价一度涨超4%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1150619526","media":"Tiger Newspress","summary":"Today Moderna shares once gained more than 4%. Modernasaid Tuesday its Covid-19 vaccine was 100% eff","content":"<p>Today&nbsp;Moderna&nbsp;shares&nbsp;once&nbsp;gained&nbsp;more&nbsp;than&nbsp;4%.&nbsp;</p><p><blockquote>今日Moderna股价一度涨超4%。</blockquote></p><p><img src=\"https://static.tigerbbs.com/c4d4545f5ddaf3cc95708b587f6eedb0\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\">Modernasaid Tuesday its Covid-19 vaccine was 100% effective in a study of adolescents ages 12 to 17, making it the second shot behindPfizer's to demonstrate high efficacy in younger age groups.</p><p><blockquote>Moderna周二表示，其Covid-19疫苗在一项针对12至17岁青少年的研究中100%有效，这使其成为继辉瑞疫苗之后第二款在年轻群体中表现出高效的疫苗。</blockquote></p><p>The company said it plans to ask the Food and Drug Administration to expand the emergency use of its Covid vaccine for teens early next month. If approved, it would likely dramatically expand the number of shots available to middle and high school students ahead of the next school year. Pfizer and German partnerBioNTechwere clearedto use their vaccine for 12- to 15-year-olds earlier this month.</p><p><blockquote>该公司表示，计划在下月初要求美国食品和药物管理局扩大其新冠疫苗在青少年中的紧急使用范围。如果获得批准，它可能会在下一学年之前大幅增加初中和高中学生的注射数量。辉瑞和德国合作伙伴BioNTech本月早些时候获准将他们的疫苗用于12至15岁的儿童。</blockquote></p><p>\"We are encouraged that mRNA-1273 was highly effective at preventing COVID-19 in adolescents,\" Moderna CEO Stephane Bancel said in a press release. \"We remain committed to doing our part to help end the COVID-19 pandemic.\"</p><p><blockquote>Moderna首席执行官Stephane Bancel在一份新闻稿中表示：“我们感到鼓舞的是，mRNA-1273在预防青少年COVID-19方面非常有效。”“我们仍然致力于尽自己的一份力量来帮助结束COVID-19大流行。”</blockquote></p><p>The two-dose vaccine, which is given four weeks apart, is already authorized for adults.</p><p><blockquote>这种间隔四周接种的两剂疫苗已经被批准用于成人。</blockquote></p><p>U.S. regulators are expected to grant Moderna's request for use in teens. The approval process could take about a month, just in time for some summer activities and fall classes if Moderna submits the data by early June. Pfizer and BioNTech requested expanded use of their shot in adolescents on April 9, for example, and were authorized by the FDA on May 10.</p><p><blockquote>预计美国监管机构将批准Moderna在青少年中使用的请求。如果Moderna在6月初提交数据，审批过程可能需要大约一个月的时间，正好赶上一些夏季活动和秋季课程。例如，辉瑞和BioNTech于4月9日要求在青少年中扩大使用他们的疫苗，并于5月10日获得FDA授权。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna shares once gained more than 4%<blockquote>Moderna股价一度涨超4%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna shares once gained more than 4%<blockquote>Moderna股价一度涨超4%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-05-25 22:01</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Today&nbsp;Moderna&nbsp;shares&nbsp;once&nbsp;gained&nbsp;more&nbsp;than&nbsp;4%.&nbsp;</p><p><blockquote>今日Moderna股价一度涨超4%。</blockquote></p><p><img src=\"https://static.tigerbbs.com/c4d4545f5ddaf3cc95708b587f6eedb0\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\">Modernasaid Tuesday its Covid-19 vaccine was 100% effective in a study of adolescents ages 12 to 17, making it the second shot behindPfizer's to demonstrate high efficacy in younger age groups.</p><p><blockquote>Moderna周二表示，其Covid-19疫苗在一项针对12至17岁青少年的研究中100%有效，这使其成为继辉瑞疫苗之后第二款在年轻群体中表现出高效的疫苗。</blockquote></p><p>The company said it plans to ask the Food and Drug Administration to expand the emergency use of its Covid vaccine for teens early next month. If approved, it would likely dramatically expand the number of shots available to middle and high school students ahead of the next school year. Pfizer and German partnerBioNTechwere clearedto use their vaccine for 12- to 15-year-olds earlier this month.</p><p><blockquote>该公司表示，计划在下月初要求美国食品和药物管理局扩大其新冠疫苗在青少年中的紧急使用范围。如果获得批准，它可能会在下一学年之前大幅增加初中和高中学生的注射数量。辉瑞和德国合作伙伴BioNTech本月早些时候获准将他们的疫苗用于12至15岁的儿童。</blockquote></p><p>\"We are encouraged that mRNA-1273 was highly effective at preventing COVID-19 in adolescents,\" Moderna CEO Stephane Bancel said in a press release. \"We remain committed to doing our part to help end the COVID-19 pandemic.\"</p><p><blockquote>Moderna首席执行官Stephane Bancel在一份新闻稿中表示：“我们感到鼓舞的是，mRNA-1273在预防青少年COVID-19方面非常有效。”“我们仍然致力于尽自己的一份力量来帮助结束COVID-19大流行。”</blockquote></p><p>The two-dose vaccine, which is given four weeks apart, is already authorized for adults.</p><p><blockquote>这种间隔四周接种的两剂疫苗已经被批准用于成人。</blockquote></p><p>U.S. regulators are expected to grant Moderna's request for use in teens. The approval process could take about a month, just in time for some summer activities and fall classes if Moderna submits the data by early June. Pfizer and BioNTech requested expanded use of their shot in adolescents on April 9, for example, and were authorized by the FDA on May 10.</p><p><blockquote>预计美国监管机构将批准Moderna在青少年中使用的请求。如果Moderna在6月初提交数据，审批过程可能需要大约一个月的时间，正好赶上一些夏季活动和秋季课程。例如，辉瑞和BioNTech于4月9日要求在青少年中扩大使用他们的疫苗，并于5月10日获得FDA授权。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1150619526","content_text":"Today Moderna shares once gained more than 4%. Modernasaid Tuesday its Covid-19 vaccine was 100% effective in a study of adolescents ages 12 to 17, making it the second shot behindPfizer's to demonstrate high efficacy in younger age groups.The company said it plans to ask the Food and Drug Administration to expand the emergency use of its Covid vaccine for teens early next month. If approved, it would likely dramatically expand the number of shots available to middle and high school students ahead of the next school year. Pfizer and German partnerBioNTechwere clearedto use their vaccine for 12- to 15-year-olds earlier this month.\"We are encouraged that mRNA-1273 was highly effective at preventing COVID-19 in adolescents,\" Moderna CEO Stephane Bancel said in a press release. \"We remain committed to doing our part to help end the COVID-19 pandemic.\"The two-dose vaccine, which is given four weeks apart, is already authorized for adults.U.S. regulators are expected to grant Moderna's request for use in teens. The approval process could take about a month, just in time for some summer activities and fall classes if Moderna submits the data by early June. Pfizer and BioNTech requested expanded use of their shot in adolescents on April 9, for example, and were authorized by the FDA on May 10.","news_type":1,"symbols_score_info":{"MRNA":0.9}},"isVote":1,"tweetType":1,"viewCount":353,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":371497498,"gmtCreate":1618964621214,"gmtModify":1631887103988,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3575416215572570","idStr":"3575416215572570"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SNOW\">$Snowflake(SNOW)$</a>winter snow","listText":"<a href=\"https://laohu8.com/S/SNOW\">$Snowflake(SNOW)$</a>winter snow","text":"$Snowflake(SNOW)$winter snow","images":[{"img":"https://static.tigerbbs.com/67a9078debe32abd7ba2780179c8e0d3","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/371497498","isVote":1,"tweetType":1,"viewCount":603,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":357781563,"gmtCreate":1617299401052,"gmtModify":1634521525203,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3575416215572570","idStr":"3575416215572570"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CNEY\">$CN Energy Group Inc.(CNEY)$</a>when going up","listText":"<a href=\"https://laohu8.com/S/CNEY\">$CN Energy Group Inc.(CNEY)$</a>when going up","text":"$CN Energy Group Inc.(CNEY)$when going up","images":[{"img":"https://static.tigerbbs.com/3fc6bb6b87b49fccd6b63135ae46cbf4","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/357781563","isVote":1,"tweetType":1,"viewCount":564,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":152079134,"gmtCreate":1625246233128,"gmtModify":1633942097458,"author":{"id":"3575416215572570","authorId":"3575416215572570","name":"WilliamTeo","avatar":"https://static.tigerbbs.com/665764fc5f5e89c64f2caa13df0fe1e3","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3575416215572570","idStr":"3575416215572570"},"themes":[],"htmlText":"Go there","listText":"Go there","text":"Go there","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/152079134","repostId":"2148870441","repostType":4,"isVote":1,"tweetType":1,"viewCount":402,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}